The	O
B29	B-DNA
(	I-DNA
immunoglobulin	I-DNA
beta-chain	I-DNA
)	I-DNA
gene	I-DNA
is	O
a	O
genetic	O
target	O
for	O
early	B-protein
B-cell	I-protein
factor	I-protein
.	O

Early	B-protein
B-cell	I-protein
factor	I-protein
(	O
EBF	B-protein
)	O
is	O
a	O
transcription	B-protein
factor	I-protein
suggested	O
as	O
essential	O
for	O
early	O
B-lymphocyte	B-cell_type
development	O
by	O
findings	O
in	O
mice	O
where	O
the	O
coding	O
gene	O
has	O
been	O
inactivated	O
by	O
homologous	O
disruption	O
.	O

This	O
makes	O
the	O
identification	O
of	O
genetic	O
targets	O
for	O
this	O
transcription	B-protein
factor	I-protein
pertinent	O
for	O
the	O
understanding	O
of	O
early	O
B-cell	O
development	O
.	O

The	O
lack	O
of	O
B29	B-RNA
transcripts	I-RNA
,	O
coding	O
for	O
the	O
beta	B-protein
subunit	I-protein
of	O
the	O
B-cell	O
receptor	O
complex	O
,	O
in	O
pro-B	B-cell_type
cells	I-cell_type
from	O
EBF	B-protein
-deficient	O
mice	O
suggested	O
that	O
B29	O
might	O
be	O
a	O
genetic	O
target	O
for	O
EBF	B-protein
.	O

We	O
here	O
present	O
data	O
suggesting	O
that	O
EBF	B-protein
interacts	O
with	O
three	O
independent	O
sites	O
within	O
the	O
mouse	B-DNA
B29	I-DNA
promoter	I-DNA
.	O

Furthermore	O
,	O
ectopic	O
expression	O
of	O
EBF	B-protein
in	O
HeLa	B-cell_line
cells	I-cell_line
activated	O
a	O
B29	B-DNA
promoter-controlled	I-DNA
reporter	I-DNA
construct	I-DNA
13-fold	O
and	O
induced	O
a	O
low	O
level	O
of	O
expression	O
from	O
the	O
endogenous	B-DNA
B29	I-DNA
gene	I-DNA
.	O

Finally	O
,	O
mutations	O
in	O
the	O
EBF	B-protein
binding	O
sites	O
diminished	O
B29	B-DNA
promoter	I-DNA
activity	O
in	O
pre-B	B-cell_type
cells	I-cell_type
while	O
the	O
same	O
mutations	O
did	O
not	O
have	O
as	O
striking	O
an	O
effect	O
on	O
the	O
promoter	O
function	O
in	O
B-cell	B-cell_line
lines	I-cell_line
of	O
later	O
differentiation	O
stages	O
.	O

These	O
data	O
suggest	O
that	O
the	O
B29	B-DNA
gene	I-DNA
is	O
a	O
genetic	O
target	O
for	O
EBF	B-protein
in	O
early	O
B-cell	O
development	O
.	O

MoLEcULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Jan.	NULL
1999	NULL
,	NULL
p.	NULL
392-401	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

The	NULL
B29	NULL
(	NULL
Immunoglobulin	NULL
B-Chain	NULL
)	NULL
Gene	NULL
Is	NULL
a	NULL
Genetic	NULL
Target	NULL
for	NULL
Early	NULL
B-Cell	NULL
Factor	NULL
PETER	NULL
AKERBLAD	NULL
,	NULL
MARIA	NULL
ROSBERG	NULL
,	NULL
TOMAS	NULL
LEANDERSON	NULL
,	NULL
AND	NULL
MIKAEL	NULL
SIGVARDSSON®*	NULL
Immunology	NULL
Group	NULL
,	NULL
CMB	NULL
,	NULL
Lund	NULL
University	NULL
,	NULL
S-223	NULL
62	NULL
Lund	NULL
,	NULL
Sweden	NULL
Received	NULL
3	NULL
June	NULL
1998/Returned	NULL
for	NULL
modification	NULL
30	NULL
June	NULL
1998/Accepted	NULL
17	NULL
September	NULL
1998	NULL
Early	NULL
B-cell	NULL
factor	NULL
(	NULL
EBF	NULL
)	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
suggested	NULL
as	NULL
essential	NULL
for	NULL
early	NULL
B-lymphocyte	NULL
development	NULL
by	NULL
findings	NULL
in	NULL
mice	NULL
where	NULL
the	NULL
coding	NULL
gene	NULL
has	NULL
been	NULL
inactivated	NULL
by	NULL
homologous	NULL
disruption	NULL
.	NULL

This	NULL
makes	NULL
the	NULL
identification	NULL
of	NULL
genetic	NULL
targets	NULL
for	NULL
this	NULL
transcription	NULL
factor	NULL
pertinent	NULL
for	NULL
the	NULL
understanding	NULL
of	NULL
early	NULL
B-cell	NULL
development	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
829	NULL
transcripts	NULL
,	NULL
coding	NULL
for	NULL
the	NULL
BB	NULL
subunit	NULL
of	NULL
the	NULL
B-cell	NULL
receptor	NULL
complex	NULL
,	NULL
in	NULL
pro-B	NULL
cells	NULL
from	NULL
EBF-deficient	NULL
mice	NULL
suggested	NULL
that	NULL
B29	NULL
might	NULL
be	NULL
a	NULL
genetic	NULL
target	NULL
for	NULL
EBF	NULL
.	NULL

We	NULL
here	NULL
present	NULL
data	NULL
suggesting	NULL
that	NULL
EBF	NULL
interacts	NULL
with	NULL
three	NULL
independent	NULL
sites	NULL
within	NULL
the	NULL
mouse	NULL
B29	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
EBF	NULL
in	NULL
HeLa	NULL
cells	NULL
activated	NULL
a	NULL
B29	NULL
promoter-controlled	NULL
reporter	NULL
construct	NULL
13-fold	NULL
and	NULL
induced	NULL
a	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
from	NULL
the	NULL
endogenous	NULL
B29	NULL
gene	NULL
.	NULL

Finally	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
diminished	NULL
B29	NULL
promoter	NULL
activity	NULL
in	NULL
pre-B	NULL
cells	NULL
while	NULL
the	NULL
same	NULL
mutations	NULL
did	NULL
not	NULL
have	NULL
as	NULL
striking	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
function	NULL
in	NULL
B-cell	NULL
lines	NULL
of	NULL
later	NULL
differentiation	NULL
stages	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
B29	NULL
gene	NULL
is	NULL
a	NULL
genetic	NULL
target	NULL
for	NULL
EBF	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
.	NULL

B-lymphocyte	NULL
development	NULL
is	NULL
a	NULL
complex	NULL
differentiation	NULL
process	NULL
that	NULL
generates	NULL
antibody-secreting	NULL
cells	NULL
.	NULL

One	NULL
key	NULL
issue	NULL
for	NULL
the	NULL
understanding	NULL
of	NULL
this	NULL
process	NULL
is	NULL
how	NULL
transcription	NULL
is	NULL
controlled	NULL
in	NULL
order	NULL
to	NULL
achieve	NULL
lineage-	NULL
and	NULL
stage-specific	NULL
expression	NULL
of	NULL
selected	NULL
genes	NULL
.	NULL

Transcriptional	NULL
control	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
several	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
development	NULL
of	NULL
the	NULL
B-cell	NULL
lineage	NULL
(	NULL
3	NULL
,	NULL
5	NULL
)	NULL
.	NULL

One	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
is	NULL
early	NULL
B-cell	NULL
factor	NULL
(	NULL
EBF	NULL
)	NULL
expressed	NULL
in	NULL
all	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
plasma	NULL
cell	NULL
stage	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
.	NULL

EBF	NULL
is	NULL
B-cell	NULL
restricted	NULL
but	NULL
also	NULL
expressed	NULL
in	NULL
adipocytes	NULL
and	NULL
in	NULL
olfactory	NULL
neurons	NULL
(	NULL
7	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
DNA	NULL
core	NULL
sequence	NULL
CCCNNGGG	NULL
as	NULL
a	NULL
homodimer	NULL
by	NULL
a	NULL
large	NULL
DNA	NULL
binding	NULL
domain	NULL
containing	NULL
a	NULL
zinc	NULL
coordination	NULL
motif	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
dimerization	NULL
is	NULL
mediated	NULL
by	NULL
two	NULL
«	NULL
-helixes	NULL
with	NULL
homology	NULL
to	NULL
helix	NULL
two	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
(	NULL
HLH	NULL
)	NULL
domain	NULL
found	NULL
in	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
basic	NULL
HLH	NULL
family	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

EBF	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
two	NULL
independent	NULL
transactivation	NULL
domains	NULL
,	NULL
one	NULL
located	NULL
within	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
another	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
part	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
8	NULL
)	NULL
.	NULL

EBF	NULL
interacts	NULL
functionally	NULL
with	NULL
transcription	NULL
control	NULL
elements	NULL
regulating	NULL
a	NULL
number	NULL
of	NULL
B-cell-specific	NULL
genes	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
28	NULL
)	NULL
.	NULL

The	NULL
first	NULL
identified	NULL
genetic	NULL
target	NULL
was	NULL
the	NULL
mb-1	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
«	NULL
-subunit	NULL
of	NULL
the	NULL
B-cell	NULL
receptor	NULL
complex	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
EBF	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
important	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mb-1	NULL
gene	NULL
can	NULL
be	NULL
expressed	NULL
in	NULL
cell	NULL
lines	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBF	NULL
as	NULL
well	NULL
,	NULL
demonstrating	NULL
that	NULL
this	NULL
promoter	NULL
is	NULL
not	NULL
completely	NULL
dependent	NULL
on	NULL
EBF	NULL
in	NULL
transformed	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
pre-B-cell-specific	NULL
surrogate	NULL
light-chain	NULL
genes	NULL
A5	NULL
and	NULL
VpreB	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
22	NULL
)	NULL
have	NULL
also	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
direct	NULL
targets	NULL
for	NULL
EBF	NULL
since	NULL
both	NULL
contain	NULL
EBF	NULL
binding	NULL
sites	NULL
important	NULL
for	NULL
promoter	NULL
function	NULL
(	NULL
21	NULL
,	NULL
26	NULL
,	NULL
29	NULL
)	NULL
.	NULL

This	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
EBF	NULL
in	NULL
the	NULL
imma-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Immunology	NULL
Group	NULL
,	NULL
CMB	NULL
,	NULL
Lund	NULL
University	NULL
,	NULL
Solvegatan	NULL
21	NULL
,	NULL
S-223	NULL
62	NULL
Lund	NULL
,	NULL
Sweden	NULL
.	NULL

Phone	NULL
:	NULL
46	NULL
462224160	NULL
.	NULL

Fax	NULL
:	NULL
46	NULL
462224218	NULL
.	NULL

E-mail	NULL
:	NULL
mikael.sigvardsson	NULL
@	NULL
immuno	NULL
Ju.se	NULL
.	NULL

392	NULL
ture	NULL
hematopoietic	NULL
cell	NULL
line	NULL
Ba/F3	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
A5	NULL
and	NULL
VpreB	NULL
genes	NULL
(	NULL
29	NULL
)	NULL
.	NULL

EBF	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
interact	NULL
with	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
light-chain	NULL
promoters	NULL
(	NULL
30	NULL
)	NULL
and	NULL
to	NULL
functionally	NULL
modulate	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
intron-enhancer	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Homologous	NULL
disruption	NULL
of	NULL
the	NULL
EBF	NULL
coding	NULL
gene	NULL
resulted	NULL
in	NULL
mice	NULL
lacking	NULL
IgM	NULL
expressing	NULL
B	NULL
cells	NULL
,	NULL
showing	NULL
the	NULL
necessity	NULL
for	NULL
EBF	NULL
in	NULL
the	NULL
development	NULL
of	NULL
mature	NULL
B	NULL
lymphocytes	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
developmental	NULL
block	NULL
of	NULL
B-cell	NULL
differentiation	NULL
occurred	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
,	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
Ig	NULL
recombination	NULL
but	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
expression	NULL
of	NULL
sterile	NULL
Ig	NULL
transcripts	NULL
(	NULL
Ip	NULL
and	NULL
p.0	NULL
)	NULL
and	NULL
terminal	NULL
deoxynucleotide	NULL
transferase	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
EBF	NULL
~~	NULL
mice	NULL
contained	NULL
cells	NULL
expressing	NULL
B220	NULL
and	NULL
CD43	NULL
but	NULL
not	NULL
BPI	NULL
or	NULL
heat-stable	NULL
antigen	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
cells	NULL
are	NULL
arrested	NULL
in	NULL
the	NULL
transition	NULL
from	NULL
fraction	NULL
A	NULL
(	NULL
pro-B	NULL
)	NULL
to	NULL
fraction	NULL
B	NULL
(	NULL
pre-B	NULL
)	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
inter-leukin-7	NULL
receptor	NULL
was	NULL
expressed	NULL
,	NULL
but	NULL
no	NULL
detectable	NULL
mRNA	NULL
for	NULL
Rag-1	NULL
,	NULL
Ig	NULL
«	NULL
-chain	NULL
,	NULL
VpreB	NULL
,	NULL
A5	NULL
,	NULL
or	NULL
IgB-chain	NULL
(	NULL
IgB	NULL
)	NULL
were	NULL
detected	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
IgB	NULL
(	NULL
B29	NULL
)	NULL
transcripts	NULL
was	NULL
striking	NULL
since	NULL
mRNA	NULL
coding	NULL
for	NULL
IgB	NULL
is	NULL
present	NULL
in	NULL
normal	NULL
fraction	NULL
A	NULL
pro-B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
IgB	NULL
transcripts	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
mice	NULL
homozygous	NULL
for	NULL
an	NULL
inactivated	NULL
E24	NULL
gene	NULL
(	NULL
38	NULL
)	NULL
,	NULL
which	NULL
have	NULL
a	NULL
similar	NULL
developmental	NULL
block	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
the	NULL
B29	NULL
promoter	NULL
might	NULL
be	NULL
a	NULL
genetic	NULL
target	NULL
for	NULL
EBF	NULL
.	NULL

The	NULL
B29	NULL
gene	NULL
encodes	NULL
the	NULL
B	NULL
component	NULL
of	NULL
the	NULL
B-cell	NULL
receptor	NULL
complex	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
signal	NULL
transducer	NULL
molecule	NULL
after	NULL
antigen	NULL
recognition	NULL
of	NULL
surface	NULL
Ig	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
2	NULL
,	NULL
13	NULL
,	NULL
and	NULL
14	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
B-cell	NULL
development	NULL
,	NULL
since	NULL
mice	NULL
homozygous	NULL
for	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
B29	NULL
gene	NULL
display	NULL
an	NULL
early	NULL
arrest	NULL
of	NULL
B-cell	NULL
development	NULL
,	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
D-J	NULL
but	NULL
before	NULL
VDJ	NULL
recombination	NULL
of	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
locus	NULL
(	NULL
6	NULL
)	NULL
.	NULL

829	NULL
is	NULL
expressed	NULL
in	NULL
cell	NULL
lines	NULL
representing	NULL
all	NULL
B-cell	NULL
differentiation	NULL
stages	NULL
(	NULL
11	NULL
)	NULL
;	NULL
it	NULL
was	NULL
proposed	NULL
that	NULL
there	NULL
is	NULL
a	NULL
partial	NULL
but	NULL
not	NULL
complete	NULL
overlap	NULL
of	NULL
EBF	NULL
and	NULL
B29	NULL
expression	NULL
.	NULL

The	NULL
B29	NULL
promoter	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
interact	NULL
with	NULL
IKAROS	NULL
,	NULL
OCT	NULL
,	NULL
and	NULL
Ets	NULL
proteins	NULL
(	NULL
12	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
factors	NULL
has	NULL
also	NULL
been	NULL
displayed	NULL
by	NULL
mutagenesis	NULL
experiments	NULL
where	NULL
the	NULL
Ets	NULL
and	NULL
the	NULL
OCT	NULL
protein	NULL
binding	NULL
sites	NULL
Vou	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
B29	NULL
,	NULL
A	NULL
GENETIC	NULL
TARGET	NULL
FOR	NULL
EBF	NULL
-	NULL
393	NULL
A	NULL
-164	NULL
IKAROS	NULL
-120	NULL
CaGccTeaTcaaccTecEcrcccaTAccercccrecacecaTeereccrccccrecererca	NULL
ATTCCCNNGGGAAT	NULL
ATTCCCNNGGGAAT	NULL
ATTCCCNNGGGAAT	NULL
EBF	NULL
site	NULL
2	NULL
Murine	NULL
B29	NULL
Consensus	NULL
EBF	NULL
EBF	NULL
site	NULL
1	NULL
EBF	NULL
site	NULL
3	NULL
oct	NULL
ETS	NULL
__	NULL
-so	NULL
ETS	NULL
SP1	NULL
CTMMGAGGAGACMGCTGCAGCCCA	NULL
ig-	NULL
sal	NULL
M	NULL
Fial	NULL
I	NULL
a	NULL
GGCTGACATACAGTTACATGTTTCGCCCCCAAACCTCCTTGGGCTCAGAGACAGAGCAGTG	NULL
ACCATG	NULL
Competitor	NULL
B29	NULL
site	NULL
1	NULL
B29	NULL
site	NULL
2	NULL
B29	NULL
site	NULL
3	NULL
N	NULL
Molar	NULL
Excess	NULL
-	NULL
10	NULL
100	NULL
1000	NULL
10	NULL
100	NULL
1000	NULL
10	NULL
100	NULL
1000	NULL
EBF	NULL
am	NULL
mb-1	NULL
probe	NULL
Competitor	NULL
mb-1	NULL
SP6	NULL
x	NULL
OCT	NULL
/	NULL
10	NULL
N	NULL
100	NULL
1000	NULL
trad	NULL
qua	NULL
»	NULL
7	NULL
Molar	NULL
Excess	NULL
100	NULL
1000	NULL
10	NULL
100	NULL
1000	NULL
10	NULL
EBF	NULL
=-	NULL
Ghia	NULL
mb-1	NULL
probe	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

The	NULL
829	NULL
promoter	NULL
contains	NULL
three	NULL
independent	NULL
EBF	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
B29	NULL
minimal	NULL
promoter	NULL
as	NULL
defined	NULL
by	NULL
Omori	NULL
and	NULL
Wall	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
EBF	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
a	NULL
consensus	NULL
EBF	NULL
binding	NULL
site	NULL
(	NULL
34	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
recombinant	NULL
EBF	NULL
to	NULL
the	NULL
mb-7	NULL
promoter	NULL
binding	NULL
sites	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
potential	NULL
EBF	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
B29	NULL
promoter	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
recombinant	NULL
EBF	NULL
to	NULL
the	NULL
mb-Z	NULL
promoter	NULL
binding	NULL
site	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
EBF	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
mb-7	NULL
and	NULL
SP6x	NULL
promoters	NULL
and	NULL
a	NULL
control	NULL
octamer-containing	NULL
oligonucleotide	NULL
(	NULL
OCT	NULL
)	NULL
.	NULL

F	NULL
indicates	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

were	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
function	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
B29	NULL
gene	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
under	NULL
the	NULL
control	NULL
of	NULL
repressor	NULL
elements	NULL
located	NULL
5	NULL
'	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
data	NULL
suggesting	NULL
that	NULL
EBF	NULL
binds	NULL
to	NULL
the	NULL
B29	NULL
promoter	NULL
and	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
present	NULL
data	NULL
indicating	NULL
that	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
are	NULL
of	NULL
great	NULL
importance	NULL
in	NULL
the	NULL
function	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
pre-B-cell	NULL
lines	NULL
while	NULL
they	NULL
have	NULL
less	NULL
impact	NULL
on	NULL
promoter	NULL
function	NULL
in	NULL
B-cell	NULL
lines	NULL
representing	NULL
later	NULL
developmental	NULL
stages	NULL
.	NULL

These	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
B29	NULL
gene	NULL
is	NULL
a	NULL
direct	NULL
genetic	NULL
target	NULL
for	NULL
EBF	NULL
and	NULL
would	NULL
explain	NULL
the	NULL
absence	NULL
of	NULL
B29	NULL
transcripts	NULL
in	NULL
pro-B	NULL
cells	NULL
in	NULL
EBF~'~	NULL
mice	NULL
.	NULL

394	NULL
AKERBLAD	NULL
ET	NULL
AL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Tissue	NULL
culture	NULL
conditions	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
7.5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
2	NULL
mM	NULL
pyruvate	NULL
,	NULL
50	NULL
wM	NULL
2-mercaptocthanol	NULL
,	NULL
and	NULL
50	NULL
ug	NULL
of	NULL
gentamicin	NULL
per	NULL
ml	NULL
(	NULL
all	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
AB	NULL
,	NULL
T	NULL
&	NULL
by	NULL
,	NULL
Sweden	NULL
)	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

A	NULL
total	NULL
of	NULL
250,000	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
overnight	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
in	NULL
a	NULL
24-well	NULL
plate	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
serum-free	NULL
medium	NULL
(	NULL
OPTIMEM	NULL
;	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
and	NULL
800	NULL
ul	NULL
of	NULL
the	NULL
serum-free	NULL
medium	NULL
was	NULL
added	NULL
for	NULL
transfection	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
Lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
was	NULL
diluted	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
serum-free	NULL
medium	NULL
,	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
mixed	NULL
with	NULL
the	NULL
DNA	NULL
diluted	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
serum-free	NULL
medium	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
25	NULL
min	NULL
,	NULL
and	NULL
the	NULL
combined	NULL
volume	NULL
of	NULL
200	NULL
pl	NULL
was	NULL
added	NULL
to	NULL
the	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
a	NULL
CO	NULL
;	NULL
incubator	NULL
at	NULL
37°C	NULL
for	NULL
6	NULL
h	NULL
,	NULL
after	NULL
which	NULL
the	NULL
transfection	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
replaced	NULL
by	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
40	NULL
h	NULL
,	NULL
and	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
100	NULL
pil	NULL
of	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
,	NULL
Scandinavian	NULL
Diagnostic	NULL
Services	NULL
AB	NULL
,	NULL
Falkenberg	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
then	NULL
conducted	NULL
with	NULL
15	NULL
pil	NULL
of	NULL
the	NULL
obtained	NULL
extracts	NULL
and	NULL
200	NULL
pl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

To	NULL
induce	NULL
expression	NULL
of	NULL
endogenous	NULL
B29	NULL
expression	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
2	NULL
million	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
EBF	NULL
expression	NULL
plasmid	NULL
by	NULL
a	NULL
scaled-up	NULL
Lipofectin	NULL
protocol	NULL
as	NULL
described	NULL
above	NULL
.	NULL

All	NULL
other	NULL
cell	NULL
lines	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
;	NULL
140	NULL
mM	NULL
NaC	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
25	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
0.6	NULL
mM	NULL
phosphate	NULL
,	NULL
0.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
;	NULL
)	NULL
,	NULL
and	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
reporter	NULL
gene	NULL
construct	NULL
in	NULL
0.65	NULL
ml	NULL
of	NULL
TBS	NULL
with	NULL
0.7	NULL
mg	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
30	NULL
min	NULL
at	NULL
20°C	NULL
.	NULL

After	NULL
a	NULL
single	NULL
wash	NULL
in	NULL
TBS	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
complete	NULL
RPMI	NULL
medium	NULL
in	NULL
six-well	NULL
plates	NULL
for	NULL
48	NULL
h.	NULL
Preparation	NULL
of	NULL
protein	NULL
extracts	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
by	NULL
using	NULL
20	NULL
%	NULL
of	NULL
the	NULL
protein	NULL
extract	NULL
.	NULL

Protein	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
y-°P	NULL
]	NULL
ATP	NULL
by	NULL
incubation	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
purified	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
gel	NULL
.	NULL

The	NULL
B29	NULL
probe	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
cloned	NULL
in	NULL
pGem	NULL
3Z	NULL
(	NULL
see	NULL
below	NULL
)	NULL
by	NULL
using	NULL
the	NULL
B29	NULL
EBF-3	NULL
antisense	NULL
oligonucleotide	NULL
together	NULL
with	NULL
an	NULL
SP6	NULL
primer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

This	NULL
PCR	NULL
product	NULL
includes	NULL
all	NULL
three	NULL
EBF	NULL
binding	NULL
sites	NULL
(	NULL
positions	NULL
-106	NULL
to	NULL
-152	NULL
)	NULL
but	NULL
lacks	NULL
OCT	NULL
,	NULL
Ets	NULL
,	NULL
and	NULL
SP1	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
fill-in	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
incubation	NULL
with	NULL
Klenow	NULL
fragment	NULL
.	NULL

The	NULL
B29	NULL
wild-type	NULL
promoter	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
an	NULL
SP6	NULL
primer	NULL
(	NULL
Promega	NULL
)	NULL
together	NULL
with	NULL
the	NULL
B29	NULL
antisense	NULL
primer	NULL
and	NULL
pGem	NULL
B29	NULL
as	NULL
the	NULL
template	NULL
.	NULL

The	NULL
resulting	NULL
full-length	NULL
B29	NULL
promoter	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
HaelII	NULL
and	NULL
fill-in	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
incubation	NULL
with	NULL
Klenow	NULL
fragment	NULL
,	NULL
which	NULL
generates	NULL
a	NULL
truncated	NULL
(	NULL
-88	NULL
to	NULL
-152	NULL
)	NULL
probe	NULL
.	NULL

The	NULL
mutated	NULL
#	NULL
29	NULL
promoters	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
were	NULL
also	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
RVprimer3	NULL
(	NULL
Promega	NULL
)	NULL
together	NULL
with	NULL
the	NULL
B29	NULL
antisense	NULL
primer	NULL
and	NULL
the	NULL
respective	NULL
B29	NULL
promoter	NULL
mutants	NULL
cloned	NULL
in	NULL
pGL3	NULL
basic	NULL
(	NULL
Promega	NULL
)	NULL
as	NULL
templates	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
full-length	NULL
829	NULL
promoter	NULL
mutants	NULL
were	NULL
digested	NULL
with	NULL
M/uI	NULL
and	NULL
Haelll	NULL
and	NULL
fill-in	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-°P	NULL
]	NULL
dCTP	NULL
by	NULL
incubation	NULL
with	NULL
Klenow	NULL
fragment	NULL
,	NULL
which	NULL
generates	NULL
truncated	NULL
(	NULL
-88	NULL
to	NULL
-152	NULL
)	NULL
probes	NULL
.	NULL

All	NULL
PCR-generated	NULL
probes	NULL
were	NULL
purified	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
TBE	NULL
gels	NULL
.	NULL

Nuclear	NULL
extract	NULL
or	NULL
in	NULL
vitro-transcribed-translated	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
labeled	NULL
probe	NULL
(	NULL
20,000	NULL
cpm	NULL
;	NULL
3	NULL
fmol	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
70	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
2.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
with	NULL
0.75	NULL
mg	NULL
poly	NULL
(	NULL
dl/dC	NULL
)	NULL
(	NULL
Phar-macia	NULL
)	NULL
.	NULL

DNA	NULL
competitors	NULL
were	NULL
added	NULL
10	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
TBE	NULL
gel	NULL
,	NULL
which	NULL
was	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Competitors	NULL
based	NULL
on	NULL
synthetic	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
the	NULL
molar	NULL
excesses	NULL
indicated	NULL
in	NULL
the	NULL
respective	NULL
figures	NULL
.	NULL

Full-length	NULL
829	NULL
promoters	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
(	NULL
see	NULL
below	NULL
)	NULL
and	NULL
were	NULL
added	NULL
at	NULL
the	NULL
molar	NULL
excesses	NULL
indicated	NULL
in	NULL
the	NULL
respective	NULL
figures	NULL
.	NULL

A5	NULL
full-length	NULL
promoter	NULL
and	NULL
actin	NULL
control	NULL
competitors	NULL
were	NULL
also	NULL
generated	NULL
by	NULL
PCR	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
reference	NULL
29	NULL
)	NULL
and	NULL
were	NULL
added	NULL
at	NULL
the	NULL
molar	NULL
excesses	NULL
indicated	NULL
in	NULL
the	NULL
respective	NULL
figures	NULL
Oligonucleotides	NULL
used	NULL
for	NULL
EMSAs	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
mb-7	NULL
EBF	NULL
sense	NULL
(	NULL
5'-GA	NULL
GAGAGACTCAAGGGAATTGTGG	NULL
)	NULL
,	NULL
mb-1	NULL
EBF	NULL
antisense	NULL
(	NULL
5-CCACAATT	NULL
CCCTTGAGTCTCTCTC	NULL
)	NULL
,	NULL
829	NULL
EBF-1	NULL
sense	NULL
(	NULL
5'-TAGGAGCTCCCATAGGG	NULL
TCCCTGTAGGGAT	NULL
)	NULL
,	NULL
B29	NULL
EBF-1	NULL
antisense	NULL
ATGGGAGCTCCTA	NULL
)	NULL
,	NULL
B29	NULL
EBF-2	NULL
sense	NULL
(	NULL
5'-TAGGAGCTCCCATACGGTC	NULL
CCTGGAGGGATGGT	NULL
)	NULL
,	NULL
B29	NULL
EBF-2	NULL
antisense	NULL
(	NULL
5	NULL
``	NULL
-ACCATCCCTCCAGGGA	NULL
CCGTATGGGAGCTCCTA	NULL
)	NULL
,	NULL
829	NULL
EBF-3	NULL
sense	NULL
(	NULL
5-GAGGGATGGTGCCTC	NULL
CCCTGGGTCTCAATT	NULL
)	NULL
,	NULL
829	NULL
EBF-3	NULL
antisense	NULL
(	NULL
5'-AATTGAGACCCAGGG	NULL
GAGGCACCATCCCTC	NULL
)	NULL
,	NULL
$	NULL
P6x	NULL
EBF	NULL
sense	NULL
(	NULL
5'-ATGGATTACTTTGCATAG	NULL
ATCCCTAGAGGCCAGCACAGCTGCT	NULL
)	NULL
,	NULL
$	NULL
P6x	NULL
EBF	NULL
antisense	NULL
(	NULL
5'-AGCAG	NULL
CTGTGCTGGCCTCTAGGGATCTATGCAAAGTAATCCAT	NULL
)	NULL
,	NULL
OCT	NULL
sense	NULL
(	NULL
5'-TTCATTGATTTGCATCGCATGAGACGCTAACATCGTACGTTC	NULL
)	NULL
,	NULL
OCT	NULL
antisense	NULL
(	NULL
5'-GAACGTACGATGTTAGCGTCTCATGCGATGCAAAT	NULL
CAATGAA	NULL
)	NULL
,	NULL
IKAROS	NULL
consensus	NULL
sense	NULL
(	NULL
5'-TAGAATTCTTGGGAATACCG	NULL
ATCTT	NULL
)	NULL
,	NULL
and	NULL
IKAROS	NULL
consensus	NULL
antisense	NULL
(	NULL
5'-AAGATCGGTATTCCCAAG	NULL
AATTCTA	NULL
}	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
16	NULL
B	NULL
B2g-tuc	NULL
[	NULL
]	NULL
A5s-Lue	NULL
12	NULL
Fos-Luc	NULL
C	NULL
9	NULL
=	NULL
S	NULL
#	NULL
8	NULL
0	NULL
<	NULL
C	NULL
6	NULL
wo	NULL
4	NULL
0	NULL
EBF	NULL
ng	NULL
--	NULL
100	NULL
200	NULL
400	NULL
B	NULL
HeLa+Vector	NULL
HeLa+EBF	NULL
Raji	NULL
[	NULL
mn	NULL
[	NULL
mmm	NULL
[	NULL
s	NULL
|	NULL
a=	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
B29	NULL
promoter	NULL
is	NULL
induced	NULL
by	NULL
EBF	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Luciferase	NULL
activity	NULL
assay	NULL
results	NULL
when	NULL
a	NULL
fos	NULL
,	NULL
a	NULL
A5	NULL
,	NULL
or	NULL
a	NULL
B29	NULL
promoter	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
construct	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
together	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
EBF	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
DNA	NULL
content	NULL
in	NULL
each	NULL
transfection	NULL
was	NULL
equalized	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
empty	NULL
expression	NULL
plasmid	NULL
(	NULL
cDNA3	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
four	NULL
transfections	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
HeLa	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
EBF	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
an	NULL
ethidium	NULL
bromide-stained	NULL
agarose	NULL
gel	NULL
with	NULL
the	NULL
resulting	NULL
amount	NULL
of	NULL
GADPH	NULL
(	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
)	NULL
PCR	NULL
products	NULL
obtained	NULL
from	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
or	NULL
an	NULL
EBF-containing	NULL
cDNA3	NULL
expression	NULL
plasmid	NULL
and	NULL
from	NULL
the	NULL
human	NULL
B-cell	NULL
line	NULL
Raji	NULL
.	NULL

The	NULL
data	NULL
show	NULL
a	NULL
serial	NULL
dilution	NULL
using	NULL
1	NULL
,	NULL
1/5	NULL
,	NULL
1/25	NULL
dilutions	NULL
of	NULL
the	NULL
template	NULL
cDNA	NULL
after	NULL
25	NULL
cycles	NULL
of	NULL
PCR	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
shows	NULL
an	NULL
autoradiogram	NULL
from	NULL
RT-PCR	NULL
analysis	NULL
indicating	NULL
the	NULL
amount	NULL
of	NULL
829	NULL
transcripts	NULL
in	NULL
the	NULL
same	NULL
cDNA	NULL
preparations	NULL
after	NULL
25	NULL
cycles	NULL
of	NULL
PCR	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
blotted	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
and	NULL
hybridized	NULL
to	NULL
an	NULL
internal	NULL
B29	NULL
oligonucleotide	NULL
.	NULL

The	NULL
filters	NULL
with	NULL
PCR	NULL
product	NULL
from	NULL
transfected	NULL
HeLa	NULL
cells	NULL
were	NULL
exposed	NULL
for	NULL
24	NULL
h	NULL
,	NULL
while	NULL
the	NULL
corresponding	NULL
filters	NULL
for	NULL
Raji	NULL
cells	NULL
were	NULL
exposed	NULL
for	NULL
4	NULL
h.	NULL
B29	NULL
|	NULL
-	NULL
wae	NULL
0	NULL
#	NULL
Plasmids	NULL
and	NULL
constructs	NULL
.	NULL

The	NULL
EBF	NULL
expression	NULL
plasmid	NULL
(	NULL
29	NULL
)	NULL
was	NULL
based	NULL
on	NULL
the	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
cDNA3	NULL
(	NULL
Invitrogen	NULL
BV	NULL
,	NULL
NV	NULL
Leek	NULL
,	NULL
The	NULL
Nether-lands	NULL
)	NULL
,	NULL
which	NULL
places	NULL
the	NULL
inserted	NULL
cDNA	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
cytomegalovirus	NULL
promoter	NULL
.	NULL

The	NULL
full-length	NULL
829	NULL
promoter	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
was	NULL
PCR	NULL
amplified	NULL
by	NULL
using	NULL
B29	NULL
sense	NULL
and	NULL
antisense	NULL
primers	NULL
with	NULL
genomic	NULL
mouse	NULL
DNA	NULL
as	NULL
the	NULL
template	NULL
.	NULL

The	NULL
resulting	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
in	NULL
pGem	NULL
3Z	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

Luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
based	NULL
on	NULL
the	NULL
pGL3	NULL
basic	NULL
reporter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
B29	NULL
promoter	NULL
was	NULL
isolated	NULL
as	NULL
a	NULL
Belll-Sacl	NULL
fragment	NULL
from	NULL
pGem	NULL
3Z	NULL
and	NULL
subcloned	NULL
in	NULL
the	NULL
pGL3	NULL
basic	NULL
reporter	NULL
vector	NULL
.	NULL

B29	NULL
promoters	NULL
with	NULL
mutated	NULL
EBF	NULL
sites	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
using	NULL
PCR	NULL
primer	NULL
B29M1	NULL
,	NULL
B29M2	NULL
,	NULL
B29M3	NULL
,	NULL
B29M	NULL
,	NULL
or	NULL
B29M1-3	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
6A	NULL
)	NULL
together	NULL
with	NULL
the	NULL
B29	NULL
antisense	NULL
primer	NULL
.	NULL

The	NULL
B29-containing	NULL
pGem	NULL
3Z	NULL
vector	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
.	NULL

The	NULL
resulting	NULL
829	NULL
promoter	NULL
mutants	NULL
were	NULL
cloned	NULL
blunt	NULL
in	NULL
pGL3	NULL
basic	NULL
reporter	NULL
vector	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
for	NULL
B29	NULL
promoter	NULL
constructs	NULL
included	NULL
the	NULL
following	NULL
:	NULL
B29	NULL
sense	NULL
(	NULL
5'-TAGGAGCTCCCATAGGGTCCCTGGAGGGAT	NULL
)	NULL
,	NULL
B29	NULL
antisense	NULL
(	NULL
5'-CAGAGATCTGGTCACTGCTCTGTCTCTGAGCCC	NULL
)	NULL
,	NULL
B29M	NULL
(	NULL
5'-TAGGAGCTCCCATACGGTCCCTGTAGGGATGGTGCCTCCCCTATGT	NULL
CTCAATTTGC	NULL
)	NULL
,	NULL
B29M1	NULL
(	NULL
5	NULL
-TAGGAGCTCCCATACGGTCCCTGGAGGG	NULL
ATGGT	NULL
)	NULL
,	NULL
B29M2	NULL
(	NULL
5'-TAGGAGCTCCCATAGGGTCCTTGTAGGGATGGT	NULL
GCCTCCCCTGGGTCTCAA	NULL
)	NULL
,	NULL
B29M3	NULL
(	NULL
5'-TAGGAGCTCCCATAGGGTCCC	NULL
TGGAGGGATGGTGCCTCCTCTATGTCTCAA	NULL
)	NULL
,	NULL
and	NULL
B29M1-3	NULL
(	NULL
5'-TAGGA	NULL
GCTCCCATACGGTCCITGTAGGGATGGTGCCTCCTCTATGTCTCAA	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
B29	NULL
,	NULL
A	NULL
GENETIC	NULL
TARGET	NULL
FOR	NULL
EBF	NULL
395	NULL
A	NULL
-164	NULL
-120	NULL
B29M	NULL
CAGCTGATGAAGCTGCCCTCCCATAcGGTCCCTGtAGGGATGGTGCCTCCCCTGatTCTCA	NULL
EBF	NULL
site	NULL
1	NULL
-	NULL
EBF	NULL
site	NULL
2	NULL
EBF	NULL
site	NULL
3	NULL
B	NULL
Competitor	NULL
m	NULL
B29	NULL
B29M	NULL
A5	NULL
Actin	NULL
/	NULL
\	NULL
Z	NULL
\	NULL
Z	NULL
\	NULL
Z	NULL
\	NULL
Molar	NULL
Excess	NULL
50	NULL
200	NULL
50	NULL
200	NULL
50	NULL
200	NULL
50	NULL
200	NULL
=e	NULL
-|	NULL
Apne	NULL
.	NULL

myae	NULL
~~	NULL
-	NULL
Ww	NULL
-	NULL
~	NULL
.	NULL

:	NULL
mb-1	NULL
probe	NULL
C	NULL
Competitor	NULL
-	NULL
IKAROS	NULL
B29	NULL
B29M	NULL
OCT	NULL
Molar	NULL
Excess	NULL
10	NULL
100	NULL
1000	NULL
50	NULL
200	NULL
50	NULL
200	NULL
1000	NULL
t-	NULL
10	NULL
wa	NULL
#	NULL
4	NULL
te	NULL
IKAROS	NULL
-	NULL
&	NULL
=	NULL
gore	NULL
IKAROS-probe	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
three	NULL
defined	NULL
EBF	NULL
binding	NULL
sites	NULL
impair	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
829	NULL
promoter	NULL
to	NULL
bind	NULL
EBF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
drawing	NULL
indicating	NULL
the	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
829	NULL
promoter	NULL
by	NULL
PCR	NULL
using	NULL
an	NULL
oligonucleotide	NULL
with	NULL
inserted	NULL
mutations	NULL
.	NULL

Lowercase	NULL
letters	NULL
indicate	NULL
the	NULL
mutations	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
recombinant	NULL
EBF	NULL
to	NULL
the	NULL
mb-7	NULL
promoter	NULL
EBF	NULL
binding	NULL
site	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
PCR-amplified	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
wild-type	NULL
829	NULL
(	NULL
B29	NULL
)	NULL
,	NULL
the	NULL
mutated	NULL
B29	NULL
(	NULL
B29M	NULL
)	NULL
,	NULL
or	NULL
the	NULL
A5	NULL
promoter	NULL
.	NULL

An	NULL
actin	NULL
PCR	NULL
fragment	NULL
served	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
230-238	NULL
pre-B	NULL
cells	NULL
and	NULL
a	NULL
consensus	NULL
IKAROS	NULL
binding	NULL
site	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
obtained	NULL
band	NULL
shift	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
IKAROS	NULL
consensus	NULL
binding	NULL
site	NULL
,	NULL
by	NULL
the	NULL
PCR-amplified	NULL
wild-type	NULL
(	NULL
B29	NULL
)	NULL
or	NULL
EBF	NULL
mutant	NULL
B29	NULL
(	NULL
B2IM	NULL
)	NULL
promoter	NULL
,	NULL
and	NULL
by	NULL
an	NULL
octamer-containing	NULL
oligonucleotide	NULL
(	NULL
OCT	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

F	NULL
indicates	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

Recombinant	NULL
proteins	NULL
were	NULL
generated	NULL
by	NULL
coupled	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
by	NULL
using	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.5	NULL
to	NULL
2	NULL
pl	NULL
of	NULL
a	NULL
25-pl	NULL
reaction	NULL
mix	NULL
was	NULL
used	NULL
for	NULL
EMSAs	NULL
.	NULL

RT	NULL
and	NULL
PCRs	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
from	NULL
cells	NULL
by	NULL
using	NULL
RNAzol	NULL
B	NULL
(	NULL
Tel-Test	NULL
Inc.	NULL
,	NULL
Friendswood	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

.	NULL

cDNA	NULL
was	NULL
generated	NULL
by	NULL
annealing	NULL
1	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
0.5	NULL
pg	NULL
of	NULL
dT	NULL
,	NULL
,	NULL
oligonucleotide	NULL
in	NULL
10	NULL
pl	NULL
of	NULL
dicthylpyrocarbonate-treated	NULL
water	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
200	NULL
U	NULL
of	NULL
SuperScript	NULL
RT	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
buffer	NULL
supplemented	NULL
with	NULL
0.5	NULL
mM	NULL
deoxynucleoside	NULL
triphosphate	NULL
,	NULL
10	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
20	NULL
U	NULL
of	NULL
RNase	NULL
inhibitor	NULL
(	NULL
Bochringer	NULL
Mannheim	NULL
,	NULL
Bromma	NULL
,	NULL
Sweden	NULL
)	NULL
,	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
One-twentieth	NULL
of	NULL
the	NULL
RT	NULL
reaction	NULL
mix	NULL
was	NULL
used	NULL
for	NULL
the	NULL
PCR	NULL
assays	NULL
.	NULL

PCRs	NULL
were	NULL
performed	NULL
with	NULL
1	NULL
U	NULL
of	NULL
Tag	NULL
polymerase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
buffer	NULL
supplemented	NULL
with	NULL
0.2	NULL
mM	NULL
deoxynucleoside	NULL
triphosphate	NULL
,	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
25	NULL
pl	NULL
.	NULL

The	NULL
conditions	NULL
of	NULL
each	NULL
PCR	NULL
cycle	NULL
were	NULL
94°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
60°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
30	NULL
s.	NULL
Primers	NULL
were	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
mM	NULL
.	NULL

Twenty-five	NULL
cycles	NULL
were	NULL
used	NULL
for	NULL
all	NULL
sets	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
blotted	NULL
onto	NULL
Zeta-Probe	NULL
GT	NULL
nylon	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
AB	NULL
,	NULL
Sundbyberg	NULL
,	NULL
Sweden	NULL
)	NULL
by	NULL
the	NULL
vacuum	NULL
transfer	NULL
method	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
in	NULL
0.5	NULL
M	NULL
NaHPO	NULL
,	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
at	NULL
57°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
hybridized	NULL
with	NULL
y-*°P-labeled	NULL
#	NULL
29	NULL
oligonucleotide	NULL
for	NULL
12	NULL
h	NULL
at	NULL
57°C	NULL
in	NULL
the	NULL
same	NULL
solution	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
at	NULL
room	NULL
temperature	NULL
three	NULL
times	NULL
in	NULL
40	NULL
mM	NULL
NaHPO	NULL
,	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
for	NULL
RT-PCR	NULL
included	NULL
the	NULL
following	NULL
:	NULL
29	NULL
cDNA	NULL
sense	NULL
,	NULL
exon	NULL
3	NULL
(	NULL
5'-TCTGGCAGAGCCCACGTTTCATA	NULL
)	NULL
;	NULL
829	NULL
cDNA	NULL
antisense	NULL
,	NULL
exon	NULL
6	NULL
(	NULL
5-CTCATAGGTGGCTGTCTGGTCAAT	NULL
)	NULL
;	NULL
B29	NULL
cDNA	NULL
hybridization	NULL
,	NULL
exon	NULL
3	NULL
(	NULL
5'-TGAAGCTGGAAAAGGGCCGCAT	NULL
)	NULL
}	NULL
;	NULL
GADPH	NULL
sense	NULL
(	NULL
5-CCACCCATG	NULL
GCAAATTCCATGGCA	NULL
)	NULL
;	NULL
and	NULL
GADPH	NULL
antisense	NULL
(	NULL
5'-TCTAGACGGCAGGT	NULL
CAGGTCCACC	NULL
)	NULL
.	NULL

396	NULL
AKERBLAD	NULL
ET	NULL
AL	NULL
.	NULL

230-238	NULL
15	NULL
a	NULL
e	NULL
410	NULL
5	NULL
s	NULL
3	NULL
s	NULL
o	NULL
.	NULL

5	NULL
_	NULL
$	NULL
3	NULL
@	NULL
[	NULL
+4	NULL
pGL3	NULL
B29	NULL
B29M	NULL
A20	NULL
20	NULL
_	NULL
.	NULL

7.5	NULL
>	NULL
is	NULL
B	NULL
F	NULL
a	NULL
5	NULL
``	NULL
3	NULL
C	NULL
2	NULL
10	NULL
5	NULL
5	NULL
€	NULL
5	NULL
.	NULL

&	NULL
#	NULL
C	NULL
$	NULL
0	NULL
54	NULL
e	NULL
©	NULL
£	NULL
£	NULL
pGLs	NULL
B29	NULL
B29M	NULL
pGL3	NULL
B29	NULL
B29M	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

18.81	NULL
un	NULL
wa	NULL
®	NULL
on	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
g	NULL
pGL3	NULL
B29	NULL
B29M	NULL
$	NULL
194	NULL
J558	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
pGL3	NULL
B29	NULL
B29M	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
EBF	NULL
binding	NULL
sites	NULL
are	NULL
important	NULL
for	NULL
the	NULL
function	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
resulting	NULL
activities	NULL
of	NULL
wild-type	NULL
(	NULL
B29	NULL
)	NULL
and	NULL
EBF-mutated	NULL
(	NULL
B2IM	NULL
)	NULL
#	NULL
29	NULL
promoter	NULL
constructs	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
a	NULL
basic	NULL
luciferase	NULL
vector	NULL
(	NULL
pGL3	NULL
)	NULL
after	NULL
transient	NULL
transfections	NULL
into	NULL
transformed	NULL
mouse	NULL
cells	NULL
of	NULL
the	NULL
B-cell	NULL
lineage	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
data	NULL
are	NULL
collected	NULL
from	NULL
four	NULL
transfections	NULL
and	NULL
two	NULL
independent	NULL
experiments	NULL
from	NULL
the	NULL
following	NULL
cell	NULL
lines	NULL
:	NULL
230-238	NULL
pre-B	NULL
cells	NULL
,	NULL
18.81	NULL
pre-B	NULL
cells	NULL
,	NULL
A20	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
,	NULL
and	NULL
J558	NULL
plasma	NULL
cells	NULL
.	NULL

RESULTS	NULL
EBF	NULL
interacts	NULL
with	NULL
three	NULL
independent	NULL
sites	NULL
in	NULL
the	NULL
B29	NULL
promoter	NULL
.	NULL

We	NULL
initially	NULL
examined	NULL
the	NULL
mouse	NULL
B29	NULL
promoter	NULL
for	NULL
potential	NULL
EBF	NULL
binding	NULL
sites	NULL
and	NULL
observed	NULL
three	NULL
putative	NULL
recognition	NULL
sequences	NULL
in	NULL
a	NULL
region	NULL
spanning	NULL
from	NULL
position	NULL
-160	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
with	NULL
the	NULL
three	NULL
potential	NULL
EBF	NULL
binding	NULL
sites	NULL
indicated	NULL
.	NULL

The	NULL
potential	NULL
EBF	NULL
binding	NULL
sites	NULL
were	NULL
all	NULL
located	NULL
between	NULL
bases	NULL
-150	NULL
and	NULL
-110	NULL
in	NULL
a	NULL
region	NULL
known	NULL
to	NULL
be	NULL
important	NULL
for	NULL
promoter	NULL
function	NULL
(	NULL
25	NULL
)	NULL
.	NULL

These	NULL
sites	NULL
were	NULL
also	NULL
conserved	NULL
between	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
B29	NULL
promoter	NULL
,	NULL
even	NULL
though	NULL
there	NULL
were	NULL
single	NULL
base	NULL
substitutions	NULL
within	NULL
the	NULL
sites	NULL
(	NULL
1a	NULL
,	NULL
31	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
sites	NULL
bound	NULL
to	NULL
EBF	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
EMSA	NULL
using	NULL
double-stranded	NULL
oligonucleo-tides	NULL
,	NULL
spanning	NULL
these	NULL
sites	NULL
,	NULL
as	NULL
competitors	NULL
for	NULL
binding	NULL
of	NULL
recombinant	NULL
in	NULL
vitro-translated	NULL
EBF	NULL
to	NULL
the	NULL
EBF	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
mb-1	NULL
promoter	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
binding	NULL
efficiency	NULL
of	NULL
the	NULL
B29	NULL
sites	NULL
to	NULL
that	NULL
of	NULL
other	NULL
characterized	NULL
EBF	NULL
sites	NULL
,	NULL
we	NULL
also	NULL
included	NULL
the	NULL
mb-1	NULL
and	NULL
the	NULL
SP6x	NULL
promoter	NULL
EBF	NULL
binding	NULL
sites	NULL
as	NULL
competitors	NULL
.	NULL

An	NULL
OCT	NULL
binding	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specificity	NULL
control	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
suggest	NULL
that	NULL
EBF	NULL
indeed	NULL
interacted	NULL
with	NULL
all	NULL
three	NULL
B29	NULL
promoter	NULL
sites	NULL
,	NULL
although	NULL
sites	NULL
1	NULL
and	NULL
3	NULL
appeared	NULL
to	NULL
be	NULL
of	NULL
low	NULL
affinity	NULL
.	NULL

Site	NULL
2	NULL
bound	NULL
EBF	NULL
with	NULL
a	NULL
similar	NULL
efficiency	NULL
as	NULL
the	NULL
EBF	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
mb-1	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
B29	NULL
promoter	NULL
contains	NULL
three	NULL
EBF	NULL
binding	NULL
sites	NULL
.	NULL

EBF	NULL
can	NULL
activate	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
an	NULL
HeLa	NULL
cell	NULL
.	NULL

Knowing	NULL
that	NULL
EBF	NULL
bound	NULL
to	NULL
the	NULL
B29	NULL
promoter	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
EBF	NULL
was	NULL
able	NULL
to	NULL
directly	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
a	NULL
non-B	NULL
cell	NULL
.	NULL

To	NULL
study	NULL
this	NULL
,	NULL
we	NULL
cloned	NULL
the	NULL
B29	NULL
promoter	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
in	NULL
front	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
pGL3	NULL
)	NULL
and	NULL
transfected	NULL
this	NULL
construct	NULL
together	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
EBF	NULL
into	NULL
HeLa	NULL
cells	NULL
.	NULL

Figure	NULL
2A	NULL
shows	NULL
a	NULL
diagram	NULL
of	NULL
the	NULL
resulting	NULL
luciferase	NULL
activity	NULL
from	NULL
this	NULL
experiment	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
was	NULL
induced	NULL
up	NULL
to	NULL
13-fold	NULL
upon	NULL
cotransfection	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
EBF	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
A5	NULL
promoter	NULL
,	NULL
previously	NULL
identified	NULL
as	NULL
an	NULL
EBF	NULL
target	NULL
,	NULL
was	NULL
induced	NULL
to	NULL
a	NULL
similar	NULL
level	NULL
,	NULL
while	NULL
a	NULL
fos	NULL
promoter	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
inclusion	NULL
of	NULL
an	NULL
EBF	NULL
expression	NULL
vector	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
endogenous	NULL
B29	NULL
expression	NULL
was	NULL
also	NULL
induced	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
EBF	NULL
.	NULL

The	NULL
results	NULL
when	NULL
cDNA	NULL
from	NULL
HeLa	NULL
cells	NULL
transiently	NULL
transfected	NULL
either	NULL
with	NULL
empty	NULL
or	NULL
EBF-encoding	NULL
expression	NULL
vector	NULL
were	NULL
analyzed	NULL
for	NULL
endogenous	NULL
B29	NULL
expression	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

Transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
EBF-transfected	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
RT-PCR	NULL
analysis	NULL
suggests	NULL
that	NULL
the	NULL
B29	NULL
levels	NULL
were	NULL
low	NULL
(	NULL
less	NULL
then	NULL
1	NULL
%	NULL
)	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
levels	NULL
found	NULL
in	NULL
the	NULL
Raji	NULL
B-cell	NULL
line	NULL
.	NULL

Longer	NULL
exposures	NULL
of	NULL
the	NULL
filters	NULL
revealed	NULL
a	NULL
low	NULL
level	NULL
of	NULL
B29	NULL
transcripts	NULL
also	NULL
in	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
plasmid	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
this	NULL
analysis	NULL
that	NULL
over-expression	NULL
of	NULL
EBF	NULL
in	NULL
a	NULL
non-B	NULL
cell	NULL
activates	NULL
some	NULL
transcription	NULL
from	NULL
the	NULL
B29	NULL
promoter	NULL
either	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
naked	NULL
template	NULL
or	NULL
in	NULL
the	NULL
chromatin	NULL
context	NULL
of	NULL
an	NULL
endogenous	NULL
gene	NULL
.	NULL

EBF	NULL
binding	NULL
sites	NULL
are	NULL
important	NULL
for	NULL
full	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
pre-B-cell	NULL
lines	NULL
.	NULL

Knowing	NULL
that	NULL
EBF	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
functionally	NULL
interact	NULL
with	NULL
the	NULL
B29	NULL
promoter	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
investigate	NULL
the	NULL
impact	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
function	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
at	NULL
different	NULL
differentiation	NULL
stages	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
mutations	NULL
were	NULL
introduced	NULL
in	NULL
the	NULL
three	NULL
EBF	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
mutations	NULL
were	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
introduced	NULL
to	NULL
avoid	NULL
disruption	NULL
of	NULL
other	NULL
overlapping	NULL
binding	NULL
sites	NULL
such	NULL
as	NULL
those	NULL
for	NULL
IKAROS	NULL
or	NULL
transcription	NULL
factor	NULL
E3	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
these	NULL
mutations	NULL
resulted	NULL
in	NULL
a	NULL
B29	NULL
promoter	NULL
with	NULL
impaired	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
EBF	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
EMSA	NULL
analysis	NULL
in	NULL
which	NULL
the	NULL
PCR-amplified	NULL
full-length	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
wild-type	NULL
or	NULL
EBF-mutated	NULL
promoter	NULL
fragment	NULL
was	NULL
used	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
EBF	NULL
to	NULL
the	NULL
mb-1	NULL
promoter	NULL
EBF	NULL
site	NULL
.	NULL

Figure	NULL
3B	NULL
shows	NULL
that	NULL
the	NULL
wild-type	NULL
B29	NULL
promoter	NULL
competed	NULL
at	NULL
least	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
A5	NULL
promoter	NULL
(	NULL
+1	NULL
to	NULL
-415	NULL
)	NULL
while	NULL
the	NULL
mutated	NULL
promoter	NULL
competed	NULL
with	NULL
low	NULL
efficiency	NULL
.	NULL

No	NULL
competition	NULL
was	NULL
observed	NULL
when	NULL
an	NULL
actin	NULL
PCR	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
the	NULL
control	NULL
.	NULL

The	NULL
residual	NULL
EBF	NULL
binding	NULL
capacity	NULL
of	NULL
the	NULL
mutated	NULL
B29	NULL
promoter	NULL
was	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
we	NULL
introduced	NULL
only	NULL
subtle	NULL
mutations	NULL
to	NULL
avoid	NULL
disruption	NULL
of	NULL
other	NULL
overlapping	NULL
binding	NULL
sites	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
mutations	NULL
affected	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
to	NULL
the	NULL
IKAROS	NULL
consensus	NULL
site	NULL
in	NULL
a	NULL
pre-B	NULL
cell	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extract	NULL
from	NULL
cell	NULL
line	NULL
230-238	NULL
and	NULL
a	NULL
duplex	NULL
consensus	NULL
IKAROS	NULL
binding	NULL
site	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
two	NULL
minor	NULL
complexes	NULL
and	NULL
one	NULL
major	NULL
complex	NULL
,	NULL
but	NULL
none	NULL
of	NULL
these	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
the	NULL
mutated	NULL
B29	NULL
promoter	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
proteins	NULL
in	NULL
230-238	NULL
cells	NULL
that	NULL
bind	NULL
to	NULL
an	NULL
IKAROS	NULL
consensus	NULL
binding	NULL
site	NULL
do	NULL
not	NULL
interact	NULL
efficiently	NULL
with	NULL
the	NULL
B29	NULL
promoter	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
the	NULL
mutations	NULL
introduced	NULL
in	NULL
the	NULL
EBF	NULL
sites	NULL
while	NULL
binding	NULL
of	NULL
EBF	NULL
was	NULL
impaired	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
under	NULL
the	NULL
control	NULL
of	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
the	NULL
EBF-mutated	NULL
B29	NULL
promoter	NULL
(	NULL
positions	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
B-cell	NULL
lines	NULL
representing	NULL
different	NULL
developmental	NULL
stages	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
wild-type	NULL
B29	NULL
promoter	NULL
fragment	NULL
into	NULL
the	NULL
pre-B-cell	NULL
line	NULL
230-238	NULL
or	NULL
18.81	NULL
resulted	NULL
in	NULL
a	NULL
13-fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
comparison	NULL
to	NULL
that	NULL
resulting	NULL
from	NULL
transfection	NULL
with	NULL
the	NULL
basic	NULL
reporter	NULL
vector	NULL
(	NULL
pGL3	NULL
)	NULL
.	NULL

When	NULL
the	NULL
EBF	NULL
mutant	NULL
B29	NULL
promoter	NULL
was	NULL
used	NULL
,	NULL
the	NULL
corresponding	NULL
induction	NULL
was	NULL
3.5-fold	NULL
,	NULL
a	NULL
4-fold	NULL
reduction	NULL
in	NULL
functional	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
the	NULL
same	NULL
promoter	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
cells	NULL
from	NULL
the	NULL
B-cell	NULL
lymphoma	NULL
A20	NULL
or	NULL
the	NULL
plasmacytomas	NULL
J558	NULL
and	NULL
$	NULL
194	NULL
,	NULL
the	NULL
EBF	NULL
mutations	NULL
resulted	NULL
in	NULL
less	NULL
than	NULL
a	NULL
twofold	NULL
reduction	NULL
in	NULL
the	NULL
B29	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
EBF	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
B29	NULL
transcription	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
while	NULL
other	NULL
factors	NULL
control	NULL
the	NULL
B29	NULL
gene	NULL
in	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

EBF	NULL
interacts	NULL
with	NULL
829	NULL
EBF	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
to	NULL
form	NULL
a	NULL
low-mobility	NULL
complex	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
region	NULL
from	NULL
-105	NULL
to	NULL
-152	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
pre-B	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
this	NULL
region	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
an	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
230-238	NULL
pre-B-cell	NULL
line	NULL
.	NULL

Two	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
one	NULL
major	NULL
and	NULL
one	NULL
minor	NULL
with	NULL
slower	NULL
mobility	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
B29	NULL
promoter	NULL
fragment	NULL
and	NULL
the	NULL
mb-1	NULL
EBF	NULL
binding	NULL
site	NULL
,	NULL
while	NULL
neither	NULL
of	NULL
the	NULL
complexes	NULL
was	NULL
efficiently	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
EBF	NULL
mutant	NULL
B29	NULL
promoter	NULL
,	NULL
an	NULL
IKAROS	NULL
consensus	NULL
binding	NULL
site	NULL
,	NULL
or	NULL
an	NULL
OCT	NULL
binding	NULL
site	NULL
.	NULL

We	NULL
interpret	NULL
these	NULL
data	NULL
as	NULL
suggesting	NULL
that	NULL
EBF	NULL
is	NULL
the	NULL
major	NULL
factor	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
two	NULL
complexes	NULL
that	NULL
could	NULL
be	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
mb-1	NULL
EBF	NULL
binding	NULL
site	NULL
indicated	NULL
that	NULL
the	NULL
high-mobility	NULL
complex	NULL
represented	NULL
a	NULL
B29	NULL
promoter	NULL
occupied	NULL
by	NULL
more	NULL
than	NULL
one	NULL
EBF	NULL
homodimer	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
more	NULL
carefully	NULL
,	NULL
we	NULL
used	NULL
the	NULL
B29	NULL
promoter	NULL
-105	NULL
to	NULL
-152	NULL
fragment	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
used	NULL
increasing	NULL
amounts	NULL
of	NULL
230-238	NULL
cell	NULL
nuclear	NULL
extract	NULL
or	NULL
in	NULL
vitro-translated	NULL
EBF	NULL
in	NULL
an	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
suggested	NULL
that	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
recombinant	NULL
protein	NULL
,	NULL
a	NULL
second	NULL
high-mobility	NULL
B29	NULL
,	NULL
A	NULL
GENETIC	NULL
TARGET	NULL
FOR	NULL
EBF	NULL
-	NULL
397	NULL
A	NULL
Competitor	NULL
-	NULL
B29	NULL
B29M	NULL
mb-1	NULL
IK	NULL
OCT	NULL
Actin	NULL
Molar	NULL
Excess	NULL
50	NULL
200	NULL
50	NULL
200	NULL
to00	NULL
1000	NULL
1000	NULL
200	NULL
Hino	NULL
,	NULL
Wout	NULL
|	NULL
trane	NULL
e-	NULL
_	NULL
wit	NULL
--	NULL
--	NULL
re-B29-probe	NULL
B	NULL
Protein	NULL
230-238	NULL
rEBF	NULL
im-EBF	NULL
-_	NULL
>	NULL
-urep	NULL
Ml	NULL
<	NULL
B29-probe	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
B29	NULL
promoter	NULL
interacts	NULL
with	NULL
EBF	NULL
in	NULL
230-238	NULL
pre-B	NULL
cells	NULL
and	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
multiple	NULL
EBF	NULL
homodimers	NULL
simultaneously	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
an	NULL
end-labeled	NULL
truncated	NULL
B29	NULL
promoter	NULL
spanning	NULL
nucleotides	NULL
-105	NULL
to	NULL
-152	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
230-238	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
obtained	NULL
band	NULL
shifts	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
PCR-amplified	NULL
full-length	NULL
(	NULL
+1	NULL
to	NULL
-152	NULL
)	NULL
wild-type	NULL
(	NULL
B29	NULL
)	NULL
or	NULL
EBF-mutated	NULL
(	NULL
B29M	NULL
)	NULL
829	NULL
promoter	NULL
;	NULL
the	NULL
mb-2	NULL
EBF	NULL
,	NULL
IKAROS	NULL
consensus	NULL
,	NULL
or	NULL
OCT	NULL
protein	NULL
binding	NULL
site	NULL
;	NULL
and	NULL
an	NULL
actin	NULL
PCR	NULL
fragment	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
using	NULL
the	NULL
B29	NULL
-105	NULL
to	NULL
-152	NULL
probe	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
either	NULL
230-238	NULL
pre-B-cell	NULL
nuclear	NULL
extracts	NULL
or	NULL
in	NULL
vitro-translated	NULL
recombinant	NULL
EBF	NULL
(	NULL
rEBF	NULL
)	NULL
.	NULL

F	NULL
indicates	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

complex	NULL
,	NULL
migrating	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
that	NULL
of	NULL
the	NULL
complex	NULL
found	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
was	NULL
formed	NULL
.	NULL

These	NULL
data	NULL
supported	NULL
the	NULL
idea	NULL
that	NULL
multiple	NULL
EBF	NULL
homodimers	NULL
bind	NULL
simultaneously	NULL
to	NULL
the	NULL
B29	NULL
promoter	NULL
but	NULL
do	NULL
not	NULL
discriminate	NULL
between	NULL
double	NULL
occupancy	NULL
due	NULL
to	NULL
interaction	NULL
with	NULL
two	NULL
sites	NULL
or	NULL
due	NULL
to	NULL
formation	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
on	NULL
one	NULL
site	NULL
(	NULL
7	NULL
)	NULL
.	NULL

To	NULL
address	NULL
this	NULL
,	NULL
we	NULL
introduced	NULL
mutations	NULL
in	NULL
the	NULL
individual	NULL
EBF	NULL
binding	NULL
sites	NULL
by	NULL
PCR	NULL
and	NULL
used	NULL
the	NULL
mutated	NULL
promoters	NULL
as	NULL
binding	NULL
sites	NULL
in	NULL
EMSAs	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
recombinant	NULL
EBF	NULL
.	NULL

Figure	NULL
6A	NULL
shows	NULL
the	NULL
promoter	NULL
mutants	NULL
used	NULL
,	NULL
with	NULL
the	NULL
introduced	NULL
mutations	NULL
indicated	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
these	NULL
promoter	NULL
fragments	NULL
span	NULL
a	NULL
larger	NULL
part	NULL
(	NULL
-152	NULL
to	NULL
-88	NULL
)	NULL
of	NULL
the	NULL
promoter	NULL
than	NULL
the	NULL
probe	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

When	NULL
the	NULL
wild-type	NULL
promoter	NULL
or	NULL
the	NULL
promoter	NULL
with	NULL
a	NULL
mutation	NULL
introduced	NULL
in	NULL
site	NULL
1	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
low-mobility	NULL
complex	NULL
occurred	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
mb-1	NULL
promoter	NULL
,	NULL
while	NULL
the	NULL
complex	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
was	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
promoters	NULL
carrying	NULL
mutations	NULL
in	NULL
site	NULL
2	NULL
or	NULL
3	NULL
did	NULL
not	NULL
form	NULL
any	NULL
low-mobility	NULL
EBF	NULL
complex	NULL
.	NULL

The	NULL
promoter	NULL
carrying	NULL
a	NULL
mutation	NULL
in	NULL
site	NULL
2	NULL
also	NULL
appeared	NULL
to	NULL
interact	NULL
with	NULL
EBF	NULL
with	NULL
a	NULL
reduced	NULL
affinity	NULL
,	NULL
suggest	NULL
398	NULL
AKERBLAD	NULL
ET	NULL
AL	NULL
.	NULL

EBF	NULL
site	NULL
1	NULL
-164	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

EBF	NULL
site	NULL
3	NULL
~120	NULL
EBF	NULL
site	NULL
2	NULL
B29	NULL
CAGCTGATGAAGCTGCCCTCCCATAGGGTCCCTGGAGGGATGGTGCCTCCCCTGGGTCTC	NULL
M1	NULL
CCTCCCATAcGGTC	NULL
M1-3	NULL
rEBF	NULL
Protein	NULL
m-EBF	NULL
-	NULL
W	NULL
*	NULL
Probes	NULL
B29	NULL
B29M1	NULL
M2	NULL
GGTCCtTGtAGGGA	NULL
M3	NULL
ccrectCcratGTcr	NULL
CCCTCCCATACGGTCCtTGtAGGGATGGTGCCTCCtCTatGTCT	NULL
ag	NULL
.	NULL

_	NULL
nﬂ	NULL
wan	NULL
W	NULL
B29M2	NULL
B29M3	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EBF	NULL
binding	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
low-mobility	NULL
complex	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
fragments	NULL
that	NULL
were	NULL
used	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
EBF	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

Introduced	NULL
mutations	NULL
are	NULL
indicated	NULL
by	NULL
lowercase	NULL
letters	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
analysis	NULL
with	NULL
increasing	NULL
amounts	NULL
(	NULL
0.5	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
pI	NULL
)	NULL
of	NULL
recombinant	NULL
EBF	NULL
and	NULL
20,000	NULL
cpm	NULL
of	NULL
the	NULL
indicated	NULL
end-labeled	NULL
B29	NULL
promoter	NULL
variants	NULL
as	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
band	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
was	NULL
not	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
mb-1	NULL
promoter	NULL
EBF	NULL
binding	NULL
site	NULL
.	NULL

F	NULL
indicates	NULL
free	NULL
probe	NULL
.	NULL

ing	NULL
that	NULL
site	NULL
2	NULL
is	NULL
the	NULL
major	NULL
EBF	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

These	NULL
experiments	NULL
lead	NULL
us	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
low-mobility	NULL
complex	NULL
consists	NULL
of	NULL
two	NULL
EBF	NULL
homodimers	NULL
bound	NULL
to	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
.	NULL

B29	NULL
EBF	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
are	NULL
important	NULL
for	NULL
the	NULL
full	NULL
function	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
.	NULL

Having	NULL
established	NULL
that	NULL
EBF	NULL
interacts	NULL
with	NULL
functionally	NULL
important	NULL
sites	NULL
in	NULL
the	NULL
B29	NULL
promoter	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
examine	NULL
the	NULL
individual	NULL
contributions	NULL
of	NULL
the	NULL
sites	NULL
to	NULL
promoter	NULL
function	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
introduced	NULL
point	NULL
mutations	NULL
in	NULL
site	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
or	NULL
in	NULL
all	NULL
three	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
the	NULL
individual	NULL
sites	NULL
to	NULL
the	NULL
total	NULL
EBF	NULL
affinity	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
examined	NULL
in	NULL
competition	NULL
experiments	NULL
using	NULL
recombinant	NULL
EBF	NULL
bound	NULL
to	NULL
the	NULL
mb-1	NULL
promoter	NULL
EBF	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
a	NULL
B29	NULL
promoter	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
EBF	NULL
site	NULL
1	NULL
still	NULL
competed	NULL
efficiently	NULL
for	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
site	NULL
2	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
EBF	NULL
binding	NULL
,	NULL
while	NULL
a	NULL
mutation	NULL
in	NULL
site	NULL
3	NULL
reduced	NULL
it	NULL
but	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
EBF	NULL
site	NULL
2	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
high	NULL
affinity	NULL
of	NULL
the	NULL
B29	NULL
promoter	NULL
for	NULL
EBF	NULL
.	NULL

The	NULL
point	NULL
mutations	NULL
were	NULL
more	NULL
drastic	NULL
than	NULL
those	NULL
used	NULL
in	NULL
our	NULL
initial	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
EMSA	NULL
experiment	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
shows	NULL
that	NULL
the	NULL
promoter	NULL
with	NULL
all	NULL
three	NULL
mutations	NULL
(	NULL
B29M1-3	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
EBF	NULL
to	NULL
the	NULL
mb-1	NULL
EBF	NULL
binding	NULL
site	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
the	NULL
previously	NULL
used	NULL
promoter	NULL
mutant	NULL
(	NULL
B29M	NULL
)	NULL
did	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
the	NULL
individual	NULL
sites	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
reporter	NULL
constructs	NULL
under	NULL
the	NULL
con	NULL
trol	NULL
of	NULL
the	NULL
mutated	NULL
promoters	NULL
into	NULL
18-81	NULL
pre-B	NULL
cells	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
site	NULL
1	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
function	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
while	NULL
a	NULL
mutation	NULL
in	NULL
site	NULL
2	NULL
resulted	NULL
in	NULL
a	NULL
50	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
site	NULL
3	NULL
resulted	NULL
in	NULL
a	NULL
75	NULL
%	NULL
reduc-tion	NULL
,	NULL
while	NULL
a	NULL
mutation	NULL
in	NULL
all	NULL
the	NULL
sites	NULL
resulted	NULL
in	NULL
an	NULL
80	NULL
%	NULL
reduction	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
same	NULL
observation	NULL
was	NULL
made	NULL
in	NULL
230-238	NULL
pre-B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
relatively	NULL
low	NULL
impact	NULL
of	NULL
the	NULL
mutation	NULL
on	NULL
site	NULL
2	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
this	NULL
region	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
repressor	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
affinity	NULL
for	NULL
the	NULL
repressor	NULL
may	NULL
then	NULL
compensate	NULL
for	NULL
loss	NULL
of	NULL
function	NULL
of	NULL
the	NULL
EBF	NULL
site	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
more	NULL
carefully	NULL
,	NULL
we	NULL
used	NULL
the	NULL
same	NULL
reporter	NULL
constructs	NULL
in	NULL
transient	NULL
transfections	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
assayed	NULL
the	NULL
induction	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
400	NULL
ng	NULL
of	NULL
empty	NULL
or	NULL
EBF-encoding	NULL
expression	NULL
plasmid	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
site	NULL
1	NULL
did	NULL
not	NULL
impair	NULL
induction	NULL
,	NULL
while	NULL
a	NULL
mutation	NULL
in	NULL
either	NULL
site	NULL
2	NULL
or	NULL
3	NULL
resulted	NULL
in	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
in	NULL
reporter	NULL
gene	NULL
activation	NULL
.	NULL

Mutations	NULL
in	NULL
all	NULL
three	NULL
sites	NULL
resulted	NULL
in	NULL
an	NULL
85	NULL
%	NULL
reduction	NULL
of	NULL
induced	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
are	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
greatest	NULL
importance	NULL
for	NULL
B29	NULL
promoter	NULL
function	NULL
.	NULL

DISCUSSION	NULL
The	NULL
finding	NULL
that	NULL
pro-B	NULL
cells	NULL
from	NULL
mice	NULL
carrying	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
encoding	NULL
EBF	NULL
did	NULL
not	NULL
express	NULL
the	NULL
B29	NULL
gene	NULL
suggested	NULL
Vou	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
B29	NULL
,	NULL
A	NULL
GENETIC	NULL
TARGET	NULL
FOR	NULL
EBF	NULL
-	NULL
399	NULL
A	NULL
Competitor	NULL
ome	NULL
B29	NULL
B29M1	NULL
-	NULL
B29M2	NULL
B29M3	NULL
B29M	NULL
M1-3	NULL
Arn	NULL
ATT	NULL
``	NULL
1	NULL
ATTth	NULL
AT	NULL
Th	NULL
Molar	NULL
Excess	NULL
so	NULL
100	NULL
50	NULL
100	NULL
50	NULL
100	NULL
50	NULL
100	NULL
so	NULL
100	NULL
50	NULL
100	NULL
Er	NULL
-	NULL
Wh	NULL
a	NULL
-~	NULL
W	NULL
#	NULL
w	NULL
B	NULL
18.81	NULL
pre-B	NULL
cells	NULL
14	NULL
=	NULL
3	NULL
G	NULL
<	NULL
.	NULL

10	NULL
©	NULL
6	NULL
3	NULL
0	NULL
©	NULL
5	NULL
@	NULL
3	NULL
G	NULL
g	NULL
2	NULL
r	NULL
--	NULL
e	NULL
LL	NULL
]	NULL
L	NULL
_|	NULL
[	NULL
]	NULL
pGL3	NULL
B29	NULL
M1	NULL
M2	NULL
M3	NULL
M1-3	NULL
C	NULL
HeLa	NULL
cells	NULL
30	NULL
f	NULL
,	NULL
20	NULL
€	NULL
G	NULL
<	NULL
``	NULL
C	NULL
E	NULL
10	NULL
WI	NULL
a	NULL
B29	NULL
M1-3	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

EBF	NULL
binding	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
are	NULL
important	NULL
for	NULL
high-affinity	NULL
binding	NULL
and	NULL
full	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
829	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Results	NULL
of	NULL
an	NULL
EMSA	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
of	NULL
0.5	NULL
pl	NULL
of	NULL
recombinant	NULL
in	NULL
vitro-translated	NULL
EBF	NULL
to	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
mb-7	NULL
promoter	NULL
EBF	NULL
binding	NULL
site	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
increasing	NULL
amounts	NULL
(	NULL
50	NULL
and	NULL
100	NULL
times	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
wild-type	NULL
(	NULL
B29	NULL
)	NULL
or	NULL
EBF-mutated	NULL
full-length	NULL
229	NULL
promoters	NULL
(	NULL
B29M1	NULL
,	NULL
B29M2	NULL
,	NULL
B29M3	NULL
,	NULL
M1-3	NULL
,	NULL
and	NULL
B29M	NULL
)	NULL
.	NULL

The	NULL
autoradiogram	NULL
is	NULL
cut	NULL
to	NULL
show	NULL
only	NULL
the	NULL
EBF-DNA	NULL
complex	NULL
and	NULL
not	NULL
the	NULL
free	NULL
probe	NULL
present	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Luciferase	NULL
activity	NULL
resulting	NULL
from	NULL
DEAE-mediated	NULL
transient	NULL
transfection	NULL
of	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
controlled	NULL
by	NULL
wild-type	NULL
(	NULL
B29	NULL
)	NULL
or	NULL
EBF	NULL
site-mutated	NULL
829	NULL
promoters	NULL
(	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
M3	NULL
,	NULL
and	NULL
M1-3	NULL
)	NULL
into	NULL
18-81	NULL
pre-B	NULL
cells	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
results	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Resulting	NULL
induction	NULL
of	NULL
activity	NULL
of	NULL
250	NULL
ng	NULL
of	NULL
829	NULL
promoter-controlled	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
400	NULL
ng	NULL
of	NULL
EBF	NULL
expression	NULL
plasmid	NULL
after	NULL
Lipofectin-mediated	NULL
transient	NULL
transfections	NULL
into	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
DNA	NULL
content	NULL
in	NULL
each	NULL
transfection	NULL
was	NULL
normalized	NULL
with	NULL
empty	NULL
expression	NULL
plasmid	NULL
(	NULL
cDNA3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
data	NULL
are	NULL
taken	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

Induction	NULL
was	NULL
calculated	NULL
based	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
different	NULL
promoter	NULL
constructs	NULL
when	NULL
transfected	NULL
together	NULL
with	NULL
400	NULL
ng	NULL
of	NULL
empty	NULL
expression	NULL
plasmid	NULL
.	NULL

to	NULL
us	NULL
that	NULL
B29	NULL
may	NULL
be	NULL
a	NULL
genetic	NULL
target	NULL
for	NULL
EBF	NULL
.	NULL

Examination	NULL
of	NULL
HeLa	NULL
cells	NULL
resulted	NULL
in	NULL
induction	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

EMSAs	NULL
the	NULL
promoter	NULL
sequence	NULL
revealed	NULL
three	NULL
potential	NULL
EBF	NULL
binding	NULL
showed	NULL
that	NULL
EBF	NULL
bound	NULL
to	NULL
the	NULL
B29	NULL
promoter	NULL
in	NULL
pre-B-cell	NULL
sites	NULL
within	NULL
160	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
main	NULL
transcription	NULL
initia-	NULL
extracts	NULL
and	NULL
transient	NULL
transfections	NULL
showed	NULL
that	NULL
the	NULL
binding	NULL
tion	NULL
site	NULL
.	NULL

All	NULL
three	NULL
sites	NULL
were	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
EBF	NULL
,	NULL
sites	NULL
were	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
affinities	NULL
varied	NULL
from	NULL
high	NULL
to	NULL
low	NULL
among	NULL
the	NULL
sites	NULL
.	NULL

we	NULL
suggest	NULL
that	NULL
EBF	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
Furthermore	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
EBF	NULL
can	NULL
interact	NULL
functionally	NULL
control	NULL
of	NULL
the	NULL
B29	NULL
gene	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

with	NULL
the	NULL
B29	NULL
promoter	NULL
since	NULL
ectopic	NULL
expression	NULL
of	NULL
EBF	NULL
in	NULL
EBF	NULL
is	NULL
not	NULL
a	NULL
unique	NULL
activator	NULL
of	NULL
B29	NULL
transcription	NULL
,	NULL
since	NULL
it	NULL
400	NULL
AKERBLAD	NULL
ET	NULL
AL	NULL
.	NULL

has	NULL
been	NULL
shown	NULL
that	NULL
B29	NULL
can	NULL
be	NULL
expressed	NULL
in	NULL
cell	NULL
lines	NULL
where	NULL
EBF	NULL
is	NULL
not	NULL
detected	NULL
.	NULL

Thus	NULL
,	NULL
B29	NULL
transcripts	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
both	NULL
the	NULL
bone	NULL
marrow-derived	NULL
cell	NULL
line	NULL
Ba/F3	NULL
that	NULL
lacks	NULL
EBF	NULL
(	NULL
29	NULL
)	NULL
and	NULL
in	NULL
plasma	NULL
cell	NULL
lines	NULL
that	NULL
should	NULL
be	NULL
devoid	NULL
of	NULL
EBF	NULL
(	NULL
11	NULL
)	NULL
.	NULL

This	NULL
probably	NULL
reflects	NULL
the	NULL
fact	NULL
that	NULL
other	NULL
DNA	NULL
binding	NULL
factors	NULL
like	NULL
OCT	NULL
and	NULL
Ets	NULL
family	NULL
proteins	NULL
can	NULL
interact	NULL
with	NULL
,	NULL
and	NULL
activate	NULL
,	NULL
the	NULL
promoter	NULL
(	NULL
25	NULL
,	NULL
31	NULL
)	NULL
.	NULL

This	NULL
resembles	NULL
the	NULL
situation	NULL
found	NULL
in	NULL
the	NULL
mb-1	NULL
promoter	NULL
,	NULL
where	NULL
EBF	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
one	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
with	NULL
functional	NULL
importance	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
slight	NULL
reduction	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
plasma	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
EBF	NULL
binding	NULL
sites	NULL
overlap	NULL
with	NULL
another	NULL
factor	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

One	NULL
such	NULL
candidate	NULL
would	NULL
be	NULL
the	NULL
factor	NULL
defined	NULL
as	NULL
BF/FA	NULL
(	NULL
18	NULL
,	NULL
30	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
octamer-dependent	NULL
activation	NULL
of	NULL
the	NULL
$	NULL
P6x	NULL
promoter	NULL
.	NULL

Even	NULL
though	NULL
B29	NULL
can	NULL
be	NULL
expressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBF	NULL
,	NULL
the	NULL
role	NULL
of	NULL
EBF	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
B29	NULL
may	NULL
still	NULL
be	NULL
pivotal	NULL
in	NULL
normal	NULL
early	NULL
B-cell	NULL
development	NULL
since	NULL
EBF-deficient	NULL
mice	NULL
lack	NULL
B29	NULL
transcripts	NULL
in	NULL
the	NULL
pro-B-cell	NULL
compartment	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
multiple	NULL
EBF	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
several	NULL
of	NULL
these	NULL
sites	NULL
can	NULL
be	NULL
occupied	NULL
simultaneously	NULL
even	NULL
with	NULL
a	NULL
large	NULL
excess	NULL
of	NULL
binding	NULL
sites	NULL
indicate	NULL
that	NULL
EBF	NULL
may	NULL
bind	NULL
cooperatively	NULL
to	NULL
sites	NULL
2	NULL
and	NULL
3	NULL
in	NULL
the	NULL
B29	NULL
promoter	NULL
.	NULL

This	NULL
is	NULL
,	NULL
however	NULL
,	NULL
weakly	NULL
supported	NULL
by	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
individual	NULL
sites	NULL
since	NULL
only	NULL
the	NULL
mutation	NULL
in	NULL
site	NULL
3	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
explanation	NULL
for	NULL
this	NULL
may	NULL
come	NULL
from	NULL
experiments	NULL
by	NULL
Omori	NULL
and	NULL
Wall	NULL
(	NULL
25	NULL
)	NULL
that	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
repressor	NULL
activity	NULL
overlapping	NULL
with	NULL
site	NULL
2	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
EBF	NULL
site	NULL
2	NULL
would	NULL
then	NULL
result	NULL
in	NULL
the	NULL
neutralization	NULL
of	NULL
both	NULL
EBF	NULL
and	NULL
repressor	NULL
activities	NULL
,	NULL
to	NULL
result	NULL
in	NULL
only	NULL
a	NULL
modest	NULL
loss	NULL
of	NULL
function	NULL
.	NULL

Functional	NULL
cooperation	NULL
also	NULL
could	NULL
not	NULL
be	NULL
supported	NULL
by	NULL
induction	NULL
experiments	NULL
with	NULL
HeLa	NULL
cells	NULL
,	NULL
where	NULL
a	NULL
mutation	NULL
in	NULL
either	NULL
site	NULL
2	NULL
or	NULL
3	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
modest	NULL
reduction	NULL
of	NULL
activity	NULL
.	NULL

This	NULL
could	NULL
depend	NULL
on	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
EBF	NULL
levels	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
high	NULL
,	NULL
which	NULL
may	NULL
compensate	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
affinity	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
one	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
contribution	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
independent	NULL
sites	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
EBF	NULL
to	NULL
bind	NULL
cooperatively	NULL
to	NULL
target	NULL
genes	NULL
are	NULL
therefore	NULL
still	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
the	NULL
large	NULL
number	NULL
of	NULL
EBF	NULL
target	NULL
genes	NULL
carrying	NULL
multiple	NULL
EBF	NULL
binding	NULL
sites	NULL
in	NULL
their	NULL
promoters	NULL
suggests	NULL
that	NULL
cooperative	NULL
binding	NULL
and	NULL
activation	NULL
may	NULL
be	NULL
a	NULL
common	NULL
theme	NULL
in	NULL
promoter	NULL
activation	NULL
by	NULL
EBF	NULL
.	NULL

The	NULL
B29	NULL
gene	NULL
is	NULL
the	NULL
fourth	NULL
important	NULL
target	NULL
gene	NULL
defined	NULL
for	NULL
EBF	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
EBF	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
mb-1	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
of	NULL
the	NULL
A5	NULL
and	NULL
VpreB	NULL
genes	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
that	NULL
EBF	NULL
is	NULL
a	NULL
pleiotropic	NULL
activator	NULL
of	NULL
early	NULL
B-cell-specific	NULL
genes	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
role	NULL
of	NULL
MyoD	NULL
in	NULL
myocyte	NULL
development	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
36	NULL
and	NULL
37	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
MyoD	NULL
,	NULL
however	NULL
,	NULL
there	NULL
are	NULL
no	NULL
data	NULL
supporting	NULL
the	NULL
possibility	NULL
that	NULL
EBF	NULL
would	NULL
be	NULL
a	NULL
master	NULL
regulator	NULL
of	NULL
B-cell	NULL
development	NULL
,	NULL
able	NULL
to	NULL
initiate	NULL
the	NULL
full	NULL
developmental	NULL
program	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
it	NULL
appears	NULL
as	NULL
if	NULL
B-cell	NULL
fate	NULL
determination	NULL
is	NULL
initiated	NULL
at	NULL
a	NULL
stage	NULL
before	NULL
EBF	NULL
expression	NULL
since	NULL
EBF	NULL
~'~	NULL
mice	NULL
still	NULL
develop	NULL
fraction	NULL
A	NULL
pro-B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
EBF	NULL
in	NULL
the	NULL
immature	NULL
hematopoietic	NULL
cell	NULL
line	NULL
Ba/F3	NULL
resulted	NULL
only	NULL
in	NULL
activation	NULL
of	NULL
certain	NULL
pre-B-cell-specific	NULL
genes	NULL
(	NULL
29	NULL
)	NULL
,	NULL
which	NULL
would	NULL
suggest	NULL
that	NULL
EBF	NULL
controls	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
genes	NULL
important	NULL
for	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Neither	NULL
does	NULL
EBF	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
MyoD	NULL
,	NULL
appear	NULL
to	NULL
regulate	NULL
its	NULL
own	NULL
transcription	NULL
(	NULL
30a	NULL
)	NULL
.	NULL

A	NULL
positive	NULL
autoregulation	NULL
may	NULL
be	NULL
an	NULL
important	NULL
feature	NULL
for	NULL
a	NULL
fate-determining	NULL
factor	NULL
to	NULL
maintain	NULL
its	NULL
own	NULL
activity	NULL
and	NULL
drive	NULL
differentiation	NULL
processes	NULL
.	NULL

An	NULL
alternative	NULL
possibility	NULL
would	NULL
be	NULL
that	NULL
EBF	NULL
acts	NULL
together	NULL
with	NULL
another	NULL
transcription	NULL
factor	NULL
to	NULL
initiate	NULL
the	NULL
full	NULL
differentiation	NULL
program	NULL
.	NULL

Such	NULL
a	NULL
synergy	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
adipogenesis	NULL
where	NULL
PPARy2	NULL
and	NULL
C/EBPa	NULL
co	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

operate	NULL
to	NULL
drive	NULL
a	NULL
fibroblast	NULL
into	NULL
an	NULL
adipocyte	NULL
(	NULL
32	NULL
)	NULL
and	NULL
in	NULL
myogenesis	NULL
where	NULL
coexpression	NULL
of	NULL
myeloid	NULL
HLH	NULL
proteins	NULL
with	NULL
MEF2	NULL
induces	NULL
myogenesis	NULL
(	NULL
23	NULL
)	NULL
.	NULL

One	NULL
such	NULL
cooperation	NULL
partner	NULL
for	NULL
EBF	NULL
is	NULL
the	NULL
E24	NULL
-encoded	NULL
HLH	NULL
transcription	NULL
factor	NULL
E47	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
15	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
a	NULL
functional	NULL
£24	NULL
gene	NULL
display	NULL
a	NULL
B-cell	NULL
differentiation	NULL
block	NULL
with	NULL
similarities	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
EBF-deficient	NULL
mice	NULL
(	NULL
1b	NULL
,	NULL
19	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
EBF	NULL
and	NULL
E47	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
in	NULL
synergy	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
the	NULL
B-cell-specific	NULL
genes	NULL
A5	NULL
and	NULL
VpreB	NULL
(	NULL
29	NULL
)	NULL
but	NULL
,	NULL
again	NULL
,	NULL
they	NULL
only	NULL
induced	NULL
expression	NULL
of	NULL
some	NULL
early	NULL
B-cell	NULL
markers	NULL
in	NULL
stably	NULL
transfected	NULL
Ba/F3	NULL
cells	NULL
.	NULL

The	NULL
apparent	NULL
lack	NULL
of	NULL
a	NULL
master	NULL
gene	NULL
activity	NULL
for	NULL
B-cell	NULL
development	NULL
may	NULL
reflect	NULL
an	NULL
inherent	NULL
difference	NULL
in	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
developmental	NULL
process	NULL
from	NULL
a	NULL
fibroblast	NULL
to	NULL
a	NULL
myocyte	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
more	NULL
complex	NULL
B-lymphoid	NULL
differentiation	NULL
process	NULL
.	NULL

Even	NULL
though	NULL
both	NULL
A5	NULL
and	NULL
B29	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
early	NULL
B-cell	NULL
development	NULL
(	NULL
6	NULL
,	NULL
16	NULL
)	NULL
,	NULL
their	NULL
absence	NULL
can	NULL
not	NULL
explain	NULL
the	NULL
early	NULL
B-cell	NULL
differentiation	NULL
block	NULL
in	NULL
EBF-deficient	NULL
mice	NULL
.	NULL

This	NULL
makes	NULL
further	NULL
identification	NULL
of	NULL
genetic	NULL
targets	NULL
for	NULL
EBF	NULL
an	NULL
important	NULL
issue	NULL
in	NULL
the	NULL
effort	NULL
to	NULL
understand	NULL
the	NULL
earliest	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
R.	NULL
Grosschedl	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
EBF	NULL
expression	NULL
plasmid	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
the	NULL
Swedish	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
American	NULL
Cancer	NULL
Society	NULL
,	NULL
The	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
,	NULL
and	NULL
The	NULL
Crafoord	NULL
,	NULL
Osterlunds	NULL
,	NULL
and	NULL
Kocks	NULL
Foundations	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akerblad	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
and	NULL
T.	NULL
Leanderson	NULL
.	NULL

1996	NULL
.	NULL

Early	NULL
B	NULL
cell	NULL
factor	NULL
(	NULL
EBF	NULL
)	NULL
down	NULL
regulates	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
intron	NULL
enhancer	NULL
function	NULL
in	NULL
a	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

44:145-149	NULL
.	NULL

1a.Akerblad	NULL
,	NULL
P.	NULL
Unpublished	NULL
data	NULL
.	NULL

1b.Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
D.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
Kruisbeck	NULL
,	NULL
B.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
Schlissel	NULL
,	NULL
A.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
H.	NULL
te	NULL
Riele	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

2	NULL
.	NULL

Borst	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Jacobs	NULL
,	NULL
and	NULL
G.	NULL
Brouns	NULL
.	NULL

1996	NULL
.	NULL

Composition	NULL
and	NULL
function	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
and	NULL
B	NULL
cell	NULL
receptor	NULL
complexes	NULL
on	NULL
precursor	NULL
lymphocytes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:181-190	NULL
.	NULL

3	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
control	NULL
of	NULL
lymphoid	NULL
development	NULL
:	NULL
lessons	NULL
from	NULL
gene	NULL
targeting	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:336-343	NULL
.	NULL

4	NULL
.	NULL

Fitzsimmons	NULL
,	NULL
D.	NULL
,	NULL
W.	NULL
Hodsdon	NULL
,	NULL
W.	NULL
Wheat	NULL
,	NULL
S.-M.	NULL
Maira	NULL
,	NULL
B.	NULL
Wasylyk	NULL
,	NULL
and	NULL
J.	NULL
Hagman	NULL
.	NULL

1996	NULL
.	NULL

Pax-5	NULL
(	NULL
BSAP	NULL
)	NULL
recruits	NULL
Ets	NULL
proto-oncogene	NULL
family	NULL
proteins	NULL
to	NULL
form	NULL
functional	NULL
ternary	NULL
complexes	NULL
on	NULL
a	NULL
B-cell-specific	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2198-2211	NULL
.	NULL

5	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
1997	NULL
.	NULL

Transcription	NULL
factors	NULL
required	NULL
for	NULL
lymphoid	NULL
lineage	NULL
commitment	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:222-227	NULL
.	NULL

6	NULL
.	NULL

Gong	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Nussenzweig	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
an	NULL
carly	NULL
developmental	NULL
checkpoint	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
pathway	NULL
by	NULL
IgB	NULL
.	NULL

Science	NULL
272:411-414	NULL
.	NULL

7	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
A.	NULL
Travis	NULL
,	NULL
C.	NULL
Turck	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
carly	NULL
B-cell	NULL
factor	NULL
,	NULL
a	NULL
regulator	NULL
of	NULL
lymphocyte-specific	NULL
gene	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:760-773	NULL
.	NULL

8	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Gutch	NULL
,	NULL
H.	NULL
Lin	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

EBF	NULL
contains	NULL
a	NULL
novel	NULL
zinc	NULL
coordination	NULL
motif	NULL
and	NULL
multiple	NULL
dimerization	NULL
and	NULL
transcriptional	NULL
activation	NULL
domains	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2907-2916	NULL
.	NULL

9	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Travis	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
lincage-specific	NULL
nuclear	NULL
factor	NULL
regulates	NULL
mb-1	NULL
gene	NULL
transcription	NULL
at	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3409-3417	NULL
.	NULL

10	NULL
.	NULL

Hardy	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Carmack	NULL
,	NULL
S.	NULL
Shinton	NULL
,	NULL
J.	NULL
Kemp	NULL
,	NULL
and	NULL
K.	NULL
Hayakawa	NULL
.	NULL

1991	NULL
.	NULL

Resolution	NULL
and	NULL
characterization	NULL
of	NULL
pro-B	NULL
and	NULL
pre-pro-B	NULL
cell	NULL
stages	NULL
in	NULL
normal	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:1213-1225	NULL
.	NULL

11	NULL
.	NULL

Her	NULL
G.	NULL
,	NULL
D.	NULL
Eisenberg	NULL
,	NULL
P.	NULL
Kincade	NULL
,	NULL
and	NULL
R.	NULL
Wall	NULL
.	NULL

1988	NULL
.	NULL

B29	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
superfamily	NULL
exclusively	NULL
expressed	NULL
on	NULL
beta	NULL
lincage	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6890-6894	NULL
.	NULL

12	NULL
.	NULL

Hermanson	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Briskin	NULL
,	NULL
D.	NULL
Sigman	NULL
,	NULL
and	NULL
R.	NULL
Wall	NULL
.	NULL

1989	NULL
.	NULL

Immunoglobulin	NULL
enhancer	NULL
and	NULL
promoter	NULL
motifs	NULL
5	NULL
'	NULL
of	NULL
the	NULL
B29	NULL
B-cell	NULL
specific	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:7341-7345	NULL
.	NULL

13	NULL
.	NULL

Hombach	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
and	NULL
M.	NULL
Reth	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
genes	NULL
encoding	NULL
the	NULL
Ig-	NULL
«	NULL
and	NULL
Ig-B	NULL
components	NULL
of	NULL
the	NULL
IgM	NULL
antigen	NULL
receptor	NULL
complex	NULL
by	NULL
aminoterminal	NULL
sequencing	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:2795-2799	NULL
.	NULL

14	NULL
.	NULL

Hombach	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Tsubata	NULL
,	NULL
L.	NULL
Leclercq	NULL
,	NULL
H.	NULL
Stappert	NULL
,	NULL
and	NULL
M.	NULL
Reth	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
components	NULL
of	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
of	NULL
the	NULL
IgM	NULL
class	NULL
.	NULL

Nature	NULL
343:760-762	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

Kadesch	NULL
,	NULL
T.	NULL
1992	NULL
.	NULL

Helix-loop-helix	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:31-36	NULL
.	NULL

Kitamura	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Kudo	NULL
,	NULL
S.	NULL
Schaal	NULL
,	NULL
W.	NULL
Muller	NULL
,	NULL
F.	NULL
Melchers	NULL
,	NULL
and	NULL
K.	NULL
Rajewsky	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
critical	NULL
role	NULL
of	NULL
A5	NULL
protein	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
69:823-831	NULL
.	NULL

Li	NULL
,	NULL
Y.-S.	NULL
,	NULL
R.	NULL
Wasserman	NULL
,	NULL
K.	NULL
Hayakawa	NULL
,	NULL
and	NULL
R.	NULL
Hardy	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
earliest	NULL
B	NULL
lincage	NULL
stage	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

Immunity	NULL
5:527-535	NULL
.	NULL

Liberg	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
Bemark	NULL
,	NULL
and	NULL
T.	NULL
Leanderson	NULL
.	NULL

1998	NULL
.	NULL

Differentiation	NULL
specific	NULL
,	NULL
octamer	NULL
dependent	NULL
costimulation	NULL
of	NULL
x	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3899-3907	NULL
.	NULL

Lin	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Failure	NULL
of	NULL
B-cell	NULL
differentiation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
EBF	NULL
.	NULL

Nature	NULL
376:263-267	NULL
.	NULL

Malone	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Omori	NULL
,	NULL
and	NULL
R.	NULL
Wall	NULL
.	NULL

1997	NULL
.	NULL

Silencer	NULL
elements	NULL
controlling	NULL
the	NULL
B29	NULL
(	NULL
IgB	NULL
)	NULL
promoter	NULL
are	NULL
neither	NULL
promoter	NULL
nor	NULL
cell-type-specific	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:12314-12319	NULL
.	NULL

Martensson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
L-L.	NULL
Martensson	NULL
.	NULL

1997	NULL
.	NULL

Early	NULL
B	NULL
cell	NULL
factor	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
critical	NULL
for	NULL
lambdaS	NULL
core	NULL
enhancer	NULL
activity	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:315-320	NULL
.	NULL

Melchers	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Karasuyama	NULL
,	NULL
D.	NULL
Haasner	NULL
,	NULL
S.	NULL
Bauer	NULL
,	NULL
A.	NULL
Kudo	NULL
,	NULL
N.	NULL
Sakaguchi	NULL
,	NULL
B.	NULL
Jameson	NULL
,	NULL
and	NULL
A.	NULL
Rolink	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
surrogate	NULL
light	NULL
chain	NULL
in	NULL
B-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:60-68	NULL
.	NULL

Molkentin	NULL
,	NULL
J.	NULL
,	NULL
B	NULL
.	NULL

Black	NULL
,	NULL
J.	NULL
Martin	NULL
,	NULL
and	NULL
E.	NULL
Olson	NULL
.	NULL

1995	NULL
.	NULL

Cooperative	NULL
activation	NULL
of	NULL
muscle	NULL
gene	NULL
expression	NULL
by	NULL
MEF	NULL
``	NULL
and	NULL
myogenic	NULL
bHLH	NULL
proteins	NULL
.	NULL

Cell	NULL
83:1125-1136	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Bain	NULL
,	NULL
M.	NULL
van	NULL
Dijk	NULL
,	NULL
L	NULL
Engel	NULL
,	NULL
B.	NULL
Furnari	NULL
,	NULL
M.	NULL
Massari	NULL
,	NULL
J.	NULL
Matthews	NULL
,	NULL
M.	NULL
Quong	NULL
,	NULL
R.	NULL
Rivera	NULL
,	NULL
and	NULL
M.	NULL
Stuiver	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1218:129-135	NULL
.	NULL

Omori	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Wall	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
motifs	NULL
regulate	NULL
the	NULL
B	NULL
cell	NULL
specific	NULL
promoter	NULL
of	NULL
the	NULL
B29	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:11732-11727	NULL
.	NULL

Persson	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Méartensson	NULL
,	NULL
and	NULL
L	NULL
-L.	NULL
1998	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
tissue	NULL
and	NULL
differentiation	NULL
stage	NULL
specific	NULL
enhancer	NULL
of	NULL
the	NULL
VpreB1	NULL
gene	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:787-798	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

B29	NULL
,	NULL
A	NULL
GENETIC	NULL
TARGET	NULL
FOR	NULL
EBF	NULL
-	NULL
401	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1998	NULL
.	NULL

Transcriptional	NULL
control	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
by	NULL
EBF	NULL
and	NULL
E47	NULL
.	NULL

In	NULL
J.	NULL
G.	NULL
Monroe	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Molecular	NULL
biology	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Humana	NULL
Press	NULL
Inc.	NULL
,	NULL
Totowa	NULL
,	NULL
N.J.	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Oriordan	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1997	NULL
.	NULL

EBF	NULL
and	NULL
E47	NULL
collaborate	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
immunoglobulin	NULL
surrogate	NULL
light	NULL
chain	NULL
genes	NULL
.	NULL

Immunity	NULL
7:25-36	NULL
.	NULL

Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Akerblad	NULL
,	NULL
and	NULL
T.	NULL
Leanderson	NULL
.	NULL

1996	NULL
.	NULL

Early	NULL
B	NULL
cell	NULL
factor	NULL
interacts	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
x	NULL
promoters	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3788-3796	NULL
.	NULL

30a.Sigvardsson	NULL
,	NULL
M.	NULL
Unpublished	NULL
observation	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Thompson	NULL
,	NULL
A.	NULL
,	NULL
W.	NULL
Wood	NULL
,	NULL
M.	NULL
Gilly	NULL
,	NULL
M.	NULL
Damore	NULL
,	NULL
S.	NULL
Omori	NULL
,	NULL
and	NULL
R.	NULL
Wall	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
promoter	NULL
and	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
controlling	NULL
human	NULL
B29	NULL
gene	NULL
expression	NULL
.	NULL

Blood	NULL
87:666-673	NULL
.	NULL

Tontonoz	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
Hu	NULL
,	NULL
and	NULL
M.	NULL
Spiegelman	NULL
.	NULL

1994	NULL
.	NULL

Stimulation	NULL
of	NULL
adipogenesis	NULL
in	NULL
fibroblasts	NULL
by	NULL
PPARg	NULL
?	NULL

2	NULL
,	NULL
a	NULL
lipid-activated	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
79	NULL
:	NULL
1147-1156	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Hagman	NULL
,	NULL
and	NULL
R.	NULL
Grossched	NULL
]	NULL
.	NULL

1991	NULL
.	NULL

Heterogencously	NULL
initiated	NULL
transcription	NULL
from	NULL
the	NULL
pre-B-	NULL
and	NULL
B-cell-specific	NULL
mb-7	NULL
promoter	NULL
:	NULL
analysis	NULL
of	NULL
the	NULL
requirement	NULL
for	NULL
upstream	NULL
factor-binding	NULL
sites	NULL
and	NULL
initiation	NULL
site	NULL
se-quences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5756-5766	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Hagman	NULL
,	NULL
L.	NULL
Hwang	NULL
,	NULL
and	NULL
R.	NULL
Grossched	NULL
]	NULL
.	NULL

1993	NULL
.	NULL

Purification	NULL
of	NULL
early-B-cell	NULL
factor	NULL
and	NULL
characterization	NULL
of	NULL
its	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3392-3400	NULL
.	NULL

Wang	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
Reed	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
olfactory	NULL
neuronal	NULL
transcription	NULL
factor	NULL
Olf-1	NULL
by	NULL
genetic	NULL
selection	NULL
in	NULL
yeast	NULL
.	NULL

Nature	NULL
364:121-126	NULL
.	NULL

Weintraub	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
S.	NULL
Tapscott	NULL
,	NULL
M.	NULL
Thayer	NULL
,	NULL
M.	NULL
Krause	NULL
,	NULL
R.	NULL
Benezra	NULL
,	NULL
T.	NULL
Blackwell	NULL
,	NULL
D.	NULL
Turner	NULL
,	NULL
R.	NULL
Rupp	NULL
,	NULL
S.	NULL
Hollenberg	NULL
,	NULL
Y.	NULL
Zhuang	NULL
,	NULL
and	NULL
A.	NULL
Lassar	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
myoD	NULL
gene	NULL
family	NULL
:	NULL
nodal	NULL
point	NULL
during	NULL
specification	NULL
of	NULL
the	NULL
muscle	NULL
cell	NULL
lineage	NULL
.	NULL

251:761-766	NULL
.	NULL

Wright	NULL
,	NULL
W.	NULL
1992	NULL
.	NULL

Muscle	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
myogenesis	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2243-248	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875-884	NULL
.	NULL

